rfhg_35210.1

Basic information about the TSS

---

TSS ID: rfhg_35210.1 Species: human Chr: chr2		Start: 177265126 End: 177265132 Strand: -
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3213847,EH38E2054905)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK314816:0 GeneID: 4780 HGNC/MGI_ID: HGNC:7782 UniProt_ID: Nearer transcript ids and distances: ENST00000430047.1:303 ENST00000397062.8:399 NM_006164.5:399 NM_001313902.2:399 NM_001313903.2:399 BC011558:437 ENST00000462023.1:467 view more...

Gene_name: NFE2 like bZIP transcription factor 2 Gene_symbol: NFE2L2 Gene_synonyms: NRF-2 NRF2 Gene_source: HGNC:7782

TATA-Box annotation

---

Distance to TSS:	2
Nearest PromoterID:	NM_001313903
Entrez ID:	4780
Nearest Unigene:	Hs.744006
Nearest Refseq:	NM_006164
Nearest Ensembl:	ENSG00000116044
Gene Name:	NFE2 like bZIP transcription factor 2
Gene Alias:	HEBP1|IMDDHH|NRF2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.285714
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NFE2L2 p2@NFE2L2 p3@NFE2L2 p4@NFE2L2 p5@NFE2L2 p6@NFE2L2 p7@NFE2L2 p10@NFE2L2
Sample		p1@NFE2L2	p2@NFE2L2	p3@NFE2L2	p4@NFE2L2	p5@NFE2L2	p6@NFE2L2	p7@NFE2L2	p10@NFE2L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.92	0.19	0.97	3.51	1.75	0.19	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	15.38	0.61	1.01	1.82	1.62	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.20	0.19	0.39	2.70	2.51	0.19	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.89	0.42	0.42	1.46	2.49	0.00	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.82	0.22	0.45	0.67	2.70	0.90	0.22	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.95	0.39	0.19	1.74	2.33	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.34	0.22	0.44	3.27	2.18	0.44	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.24	0.00	0.73	2.91	1.94	0.73	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.40	0.00	0.00	2.14	1.50	0.21	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.65	0.00	1.16	7.54	4.06	0.00	0.00	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.83	0.00	2.83	2.83	2.43	0.00	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	0.00	1.63	5.69	2.03	0.41	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.57	6.13	3.39	9.99	1.61	1.93	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.44	11.73	5.26	8.87	1.05	1.35	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.56	9.66	5.49	10.10	1.10	2.20	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.84	10.06	5.78	8.55	1.76	1.51	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.54	12.01	5.24	6.12	0.44	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	8.01	6.75	5.91	0.00	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	12.26	4.80	5.86	2.67	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.26	14.74	5.42	8.73	1.50	2.26	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.38	13.90	4.41	8.02	1.87	1.07	0.53	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.17	17.43	5.52	7.60	2.93	1.38	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	26.63	16.54	5.82	7.50	2.20	1.55	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.35	15.53	5.10	7.77	3.40	2.18	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	34.05	19.87	5.93	5.93	3.35	1.03	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	31.33	18.36	4.11	6.01	4.43	1.27	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.73	14.29	5.49	5.49	5.49	1.65	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	56.82	30.88	8.02	7.07	8.49	2.59	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	44.58	14.38	4.04	6.78	7.43	1.13	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.06	28.41	4.34	4.16	8.14	1.99	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	53.17	22.40	2.72	4.40	10.68	1.88	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.13	23.45	3.71	5.47	9.38	0.98	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	42.63	20.89	4.22	6.33	14.77	1.06	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	64.99	34.97	9.24	7.75	15.17	1.65	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	56.47	25.80	4.49	4.86	9.16	2.06	0.19	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	58.83	21.46	4.22	5.75	10.92	1.34	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	58.25	20.85	2.45	6.54	10.01	0.41	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	54.80	25.79	1.81	4.63	12.29	1.21	0.60	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	49.43	28.63	4.59	6.48	9.99	1.08	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	46.09	21.13	2.64	4.08	9.60	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.99	18.11	2.82	5.41	7.76	1.88	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.31	21.67	5.27	5.56	9.08	1.17	1.02	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	36.27	18.77	2.74	5.06	4.85	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.94	13.81	4.55	7.34	5.77	1.22	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	49.99	23.09	3.21	7.43	7.83	0.20	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	34.90	17.68	2.79	6.75	5.12	0.93	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.62	12.48	1.92	3.60	2.64	0.24	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.38	13.11	2.09	5.07	5.07	0.00	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.32	11.01	2.15	8.62	5.74	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.48	10.72	1.21	7.89	4.45	0.40	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.22	12.30	2.66	8.20	4.10	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.23	8.23	2.00	8.67	5.34	1.11	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	69.96	0.00	13.99	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	9.58	1.77	6.74	2.84	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	11.27	2.65	7.62	3.98	0.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	31.88	5.03	13.42	2.52	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	12.40	3.67	9.64	3.67	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.32	7.78	1.94	8.43	3.24	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.77	5.46	1.61	7.71	2.57	0.64	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.69	20.12	6.92	12.57	6.29	1.89	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	27.50	10.58	1.41	5.64	2.12	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.99	9.53	2.80	7.29	2.24	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	19.90	7.17	11.15	5.57	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	9.51	3.40	10.19	4.08	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.00	5.85	1.95	8.12	1.95	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.55	6.03	3.19	8.16	2.13	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	16.16	16.16	0.00	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	71.08	39.49	15.79	31.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.86	4.88	2.93	7.31	2.44	1.46	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.33	2.98	3.97	7.93	2.48	0.50	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.01	2.81	1.88	7.97	3.28	1.41	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	6.95	7.95	5.96	1.99	1.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.78	7.42	6.81	5.88	1.24	2.17	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.26	5.81	7.03	6.73	2.14	0.92	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	45.93	13.62	2.53	1.90	5.86	0.79	1.11	0.48
Adipocyte - breast, donor2	11327-117E4	30.96	5.94	1.12	1.60	2.89	0.48	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	44.02	12.85	3.44	2.67	7.25	0.38	1.65	0.38
Adipocyte - omental, donor2	11474-119C7	41.11	5.23	3.74	2.24	0.75	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	36.84	5.02	1.67	1.67	5.02	0.33	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	45.94	3.83	2.55	0.64	1.91	0.64	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	1.10	0.00	0.00	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	1.81	0.90	0.90	3.16	0.90	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.07	2.95	0.70	2.26	1.56	0.35	1.74	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	47.52	3.13	2.35	6.45	4.30	1.76	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.57	2.06	0.51	6.18	2.06	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.27	2.79	1.95	3.90	3.07	0.84	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	35.86	7.05	1.18	3.53	2.35	1.18	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	34.75	7.96	3.46	6.52	3.78	0.72	0.64	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	37.76	5.81	3.23	7.42	1.94	0.97	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	23.46	4.27	2.67	1.07	3.73	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	6.12	1.11	3.90	1.67	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	21.21	2.08	0.83	3.74	2.50	0.00	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	26.62	4.02	2.76	3.27	1.76	1.26	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	21.27	4.58	2.29	3.27	1.96	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	16.14	4.87	2.44	1.83	2.44	0.91	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	10.61	0.66	0.88	1.33	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.89	0.00	0.00	0.72	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	2.40	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.38	0.54	0.18	1.26	0.00	0.18	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.75	0.41	0.21	1.64	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	40.05	16.13	9.15	1.49	2.86	1.14	0.80	0.23
Anulus Pulposus Cell, donor2	11463-119B5	31.59	2.45	2.94	1.22	3.92	1.22	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	6.29	5.84	1.80	0.45	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	6.95	4.34	1.30	0.87	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	10.70	4.28	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.13	5.68	3.89	0.90	1.79	0.60	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	6.32	3.79	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	2.64	4.62	1.98	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	3.25	2.92	1.30	0.97	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	18.93	3.88	2.43	1.94	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	2.97	5.34	1.19	1.19	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.46	7.91	3.77	1.13	0.38	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	5.81	2.90	1.45	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	5.02	3.76	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.57	9.72	7.58	1.81	1.48	0.66	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	2.73	1.36	1.36	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.27	6.94	4.98	2.71	0.60	0.30	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.90	4.82	3.75	0.00	0.54	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	18.70	4.91	3.21	1.32	0.57	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	6.95	3.47	1.07	1.87	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	3.90	1.95	3.90	1.95	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.74	7.46	4.48	2.16	1.49	0.50	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	7.20	0.00	2.40	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.75	6.18	4.97	1.03	1.20	1.20	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	8.39	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.53	4.85	2.91	0.49	1.94	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.66	6.45	6.07	1.14	0.76	1.90	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	6.06	1.21	2.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.10	1.14	3.99	0.00	0.00	2.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.96	1.92	3.63	0.86	0.43	0.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	2.84	2.06	2.06	0.52	0.52	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	6.57	2.82	1.41	0.47	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.76	4.50	5.47	1.29	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	6.42	2.14	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.62	5.26	1.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.16	4.22	3.61	1.20	0.90	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	5.94	1.19	2.38	2.38	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.34	5.09	5.09	1.02	0.51	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.08	4.84	4.33	0.51	1.53	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	5.72	3.81	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	17.26	3.45	3.45	1.73	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.32	5.72	5.08	1.06	1.91	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.76	5.22	2.32	0.58	0.29	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	14.17	4.72	2.83	0.94	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.48	6.44	4.75	1.02	0.85	0.68	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	6.95	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	6.34	0.00	0.00	6.34	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.94	7.08	2.36	0.43	1.29	1.07	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.64	9.63	4.21	1.80	1.80	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	8.75	5.83	1.46	0.73	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.37	9.20	5.06	1.38	0.46	1.84	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	15.30	7.65	0.00	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.81	9.41	2.29	1.53	2.29	0.51	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.02	9.70	4.75	1.03	1.65	0.62	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	8.87	4.28	0.92	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.64	10.52	5.26	1.43	0.48	0.96	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.07	5.10	3.33	1.33	1.77	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	16.78	6.10	0.00	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.94	5.54	4.98	1.66	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.89	2.91	2.65	1.32	2.38	0.53	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.08	6.18	2.91	1.45	1.09	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	8.23	0.25	2.21	1.11	0.49	0.49	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	6.16	0.00	0.86	2.05	0.17	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.08	0.00	1.47	1.89	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	36.95	9.41	9.41	5.58	1.39	9.41	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	34.46	5.18	5.34	5.01	2.91	1.94	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	36.69	2.09	3.58	5.97	1.04	1.04	0.15	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.18	0.57	2.52	14.11	1.26	3.10	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	35.45	0.00	1.75	12.65	2.13	2.00	0.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	31.52	0.23	1.59	12.06	1.25	2.05	0.11	0.11
Basophils, donor1	12241-129G9	43.41	4.97	2.62	0.26	4.97	2.35	1.83	0.26
Basophils, donor2	12242-129H1	45.46	14.07	6.86	2.89	7.58	6.13	1.80	0.00
Basophils, donor3	12243-129H2	55.86	17.35	5.44	1.47	4.70	2.06	0.59	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	23.93	0.65	0.86	1.29	0.65	0.22	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	14.17	0.00	0.00	0.46	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	14.35	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	32.64	0.63	1.26	0.00	1.88	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	23.08	0.21	0.21	0.00	1.04	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	32.70	1.38	0.92	0.92	4.38	0.92	0.69	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	37.07	9.00	3.24	1.80	1.62	1.98	0.36	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.97	0.00	0.62	5.26	2.78	1.03	0.10	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	29.11	0.00	1.16	7.22	2.79	1.16	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.50	9.59	11.51	10.55	4.16	4.48	2.24	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	83.41	18.60	3.38	1.69	9.58	0.56	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	78.32	14.66	3.16	1.86	9.47	2.23	1.30	0.19
CD14+ Monocytes, donor3	11381-118B4	89.13	13.61	3.07	3.51	10.32	1.54	3.29	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	89.16	41.04	31.13	11.89	16.70	5.09	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	124.72	31.08	25.40	9.86	10.61	7.96	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	126.24	32.22	29.26	9.53	15.45	7.56	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	94.39	14.60	7.23	0.72	5.64	0.87	0.29	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	105.61	8.75	5.43	1.51	12.97	0.91	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	111.10	12.08	7.34	1.66	8.29	1.18	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	132.08	10.71	3.01	1.17	9.04	2.85	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	173.89	6.90	1.66	0.00	19.60	1.66	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	210.24	9.67	2.48	2.23	17.60	1.74	0.25	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	217.53	21.73	4.11	0.98	13.31	3.33	1.57	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	262.62	16.38	7.48	0.18	22.61	3.92	1.25	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	347.12	29.16	9.14	0.87	34.82	6.31	1.74	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	205.56	14.52	3.28	0.00	9.37	2.11	0.00	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	345.86	14.78	3.17	1.06	23.76	2.64	3.17	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	282.89	9.98	4.44	2.22	31.06	4.44	1.11	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	110.22	9.97	3.72	0.45	6.10	1.64	0.15	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	121.52	8.18	2.99	0.80	12.57	1.00	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	148.03	16.66	6.45	0.83	19.57	2.29	0.62	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	195.38	13.04	2.75	0.46	10.52	1.14	0.23	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	226.88	14.70	4.30	1.13	27.14	2.04	1.13	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	236.13	10.04	6.98	0.87	15.71	1.75	0.44	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	194.75	22.33	6.99	0.54	11.03	4.30	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	240.93	33.67	13.08	1.40	26.52	6.98	1.22	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	252.49	20.62	11.36	1.26	25.25	6.31	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	230.37	16.17	1.10	0.73	15.98	1.29	0.18	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	265.96	9.16	1.76	1.76	29.94	1.41	0.35	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	340.89	14.48	2.19	0.00	30.27	1.32	0.00	3.51
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	187.63	13.25	6.28	0.35	10.11	4.36	0.87	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	223.75	14.12	10.04	0.37	20.44	1.86	1.12	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	296.60	28.24	9.48	1.08	30.61	6.04	1.29	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	183.86	12.28	2.05	0.41	13.92	0.82	0.00	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	303.19	13.68	5.10	1.39	37.09	3.71	0.93	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	281.87	23.20	5.10	0.23	39.21	4.41	0.23	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	49.48	9.59	5.89	6.76	3.71	1.31	1.31	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	57.52	16.17	4.39	5.08	9.24	2.08	2.54	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	50.25	8.01	3.25	3.68	6.28	1.08	2.60	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	65.40	14.64	9.34	7.63	4.05	2.34	1.25	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	51.52	6.29	4.54	4.02	5.76	1.05	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	57.53	5.13	7.14	5.80	2.45	1.34	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	55.37	0.51	0.77	5.61	6.38	1.28	1.53	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	42.82	2.20	1.10	7.47	5.49	0.66	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	42.95	1.47	0.84	4.21	3.79	0.21	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	0.00	8.13	2.03	2.03	22.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.12	0.00	8.81	5.42	8.14	16.95	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	40.39	0.00	9.32	6.21	5.18	17.61	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.38	0.00	9.06	1.60	11.19	21.85	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.95	0.00	7.50	2.68	6.43	18.23	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.10	0.00	3.51	7.02	3.51	19.65	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	0.00	4.71	6.27	3.14	21.18	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	0.00	11.86	5.27	13.18	22.41	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	41.10	0.82	3.29	1.64	9.04	4.11	5.75	0.00
CD19+ B Cells, donor2	11624-122B4	42.80	0.73	7.98	0.73	12.33	4.35	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	43.92	0.50	3.03	0.00	6.56	3.03	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	76.37	1.21	3.23	8.08	3.23	3.64	2.83	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	48.34	0.00	3.20	4.39	2.80	2.00	1.60	0.00
CD34+ Progenitors, donor1	11545-120B6	26.11	4.02	8.03	4.02	3.01	5.02	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	79.78	6.18	10.11	5.06	10.67	6.74	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	36.07	2.25	7.14	16.91	1.13	3.38	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	27.51	2.25	6.76	13.53	2.48	2.48	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	38.56	6.07	4.64	5.36	16.07	3.57	7.86	0.00
CD4+ T Cells, donor2	11306-117C1	36.74	4.29	9.80	4.29	4.90	4.29	4.29	0.61
CD4+ T Cells, donor3	11382-118B5	34.77	3.96	7.62	3.35	7.32	6.40	8.23	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	26.03	2.81	28.84	11.23	3.83	27.06	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.28	2.25	28.75	13.25	2.70	30.32	0.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.43	2.59	30.76	10.35	5.17	29.32	1.72	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	45.99	4.74	25.13	7.11	11.85	21.81	7.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.93	3.51	11.24	17.56	9.13	21.77	7.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	3.30	6.59	19.78	0.00	13.18	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.81	2.89	15.46	7.66	2.46	14.45	1.73	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.69	1.86	8.13	7.46	2.71	11.69	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.67	0.81	10.96	6.61	2.10	12.25	1.45	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	33.17	4.93	25.10	7.62	6.28	18.83	3.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.08	6.29	22.36	7.34	6.99	21.66	3.84	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	32.12	1.76	19.80	7.04	5.72	22.88	5.72	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.50	3.79	14.34	14.34	3.79	14.34	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.39	1.25	9.97	14.54	3.32	6.23	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.38	1.67	7.35	8.69	4.01	6.35	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.33	0.82	19.85	9.25	4.89	31.00	5.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	35.37	3.22	14.47	20.90	9.11	35.37	2.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	0.00	7.17	7.17	5.38	19.73	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.08	1.11	12.79	10.20	5.01	10.20	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.04	1.52	10.40	9.75	4.12	7.80	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.74	1.26	14.50	7.36	4.62	8.62	1.68	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.83	2.02	11.63	7.58	6.07	14.16	4.04	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	41.16	2.17	13.43	6.93	9.53	12.13	6.07	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.20	3.49	14.38	11.33	6.54	19.18	3.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.12	0.00	11.88	16.33	7.42	42.06	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	31.39	0.00	13.85	9.23	0.00	20.31	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	29.31	0.00	9.77	9.77	6.98	37.69	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	45.97	1.38	17.45	7.75	7.20	39.05	2.22	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.83	0.00	17.42	9.08	4.66	41.23	1.96	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	30.80	0.00	7.70	20.02	3.08	35.42	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	43.69	0.00	12.53	12.89	5.01	39.75	1.79	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	0.00	16.62	12.46	2.77	30.47	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	34.05	5.57	8.51	4.58	11.46	7.20	6.55	0.00
CD8+ T Cells, donor2	11307-117C2	31.16	1.50	7.51	3.00	7.51	4.88	5.63	0.00
CD8+ T Cells, donor3	11383-118B6	40.65	3.03	6.31	7.83	10.35	4.29	7.32	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	0.92	1.38	3.21	5.05	0.23	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.58	0.24	0.24	1.92	2.88	0.00	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.23	0.00	0.82	3.28	7.11	0.55	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.11	1.80	2.70	4.50	5.10	1.50	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.64	0.24	0.24	5.28	7.92	0.72	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.78	0.00	0.68	4.55	7.50	0.00	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.69	0.65	1.30	3.69	8.26	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.53	0.26	0.79	3.42	5.53	0.53	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.98	0.47	0.47	2.58	6.57	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.30	1.21	1.51	2.11	5.13	0.30	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	0.58	1.45	3.49	4.65	0.58	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.12	0.27	0.53	0.53	7.73	1.07	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.39	0.44	2.63	2.63	7.00	2.19	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.69	2.28	2.28	1.82	3.19	0.46	0.91	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	1.49	3.73	2.24	11.19	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.25	0.36	1.44	4.32	7.92	0.72	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	0.29	1.15	3.74	6.04	0.00	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.80	0.47	0.71	2.12	8.49	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	24.40	0.95	0.32	3.17	8.56	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.22	0.62	0.92	3.08	8.92	0.92	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.95	0.96	0.32	1.60	8.34	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.51	0.38	1.91	1.91	7.65	0.00	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.55	0.79	1.58	3.94	9.06	1.18	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	0.00	2.27	3.78	7.56	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	43.36	2.41	8.03	4.82	12.04	1.61	4.01	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.26	5.60	8.39	6.99	12.59	2.80	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	62.11	3.01	8.01	7.01	13.02	3.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	115.15	3.66	1.83	3.66	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	34.59	10.38	1.98	1.98	1.48	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	58.83	12.31	4.53	2.63	2.53	2.10	0.74	0.42
Chondrocyte - de diff, donor1	11261-116G1	36.05	6.24	5.55	2.77	2.77	1.39	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	34.83	7.11	1.07	2.49	2.13	0.00	1.78	0.71
Chondrocyte - de diff, donor3	11410-118E6	40.73	11.26	3.75	4.21	3.19	0.68	0.91	0.46
Chondrocyte - re diff, donor2	11339-117F7	34.02	6.27	8.06	4.48	5.37	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	21.43	5.26	6.47	4.04	0.40	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	28.80	3.21	10.90	8.26	2.30	2.41	0.57	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	17.32	1.28	4.06	2.99	1.71	1.07	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	21.95	1.42	4.07	4.34	2.04	1.33	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.80	3.30	4.95	10.73	4.40	4.86	1.28	2.48
Corneal Epithelial Cells, donor1	11526-119I5	13.17	0.88	0.44	1.54	0.44	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	2.28	0.00	0.00	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.34	1.79	1.02	1.53	1.02	0.51	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	46.23	6.77	16.51	7.26	11.39	3.96	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	51.10	4.42	13.56	5.36	10.72	3.78	1.26	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	10.35	3.45	6.90	6.90	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	46.22	3.78	5.29	5.18	10.37	2.16	0.22	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.15	3.07	6.15	0.00	8.54	4.44	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	39.83	1.96	6.53	0.00	8.49	3.92	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	41.62	2.42	5.81	0.48	10.65	4.36	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.84	0.33	2.00	3.17	0.50	0.83	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	1.17	1.76	0.59	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	0.00	0.85	2.26	0.28	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	17.69	0.00	1.57	0.39	0.39	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	15.42	0.58	1.45	1.75	0.87	0.87	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	24.23	0.47	2.82	1.18	0.71	2.82	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	17.36	0.35	0.53	1.40	0.35	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.06	1.77	5.54	8.64	0.66	2.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.65	3.65	6.09	4.26	0.91	2.74	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	37.49	1.41	5.92	7.61	1.13	5.36	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	20.80	0.89	3.27	0.30	2.67	1.49	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	22.91	0.52	2.60	1.04	1.04	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.60	0.14	1.28	1.28	0.57	0.57	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	33.21	0.80	1.20	2.80	1.60	2.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.92	0.00	1.05	1.05	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.83	0.62	3.98	8.57	1.99	1.37	0.00	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.29	0.22	1.30	6.52	1.30	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.65	0.49	0.98	7.21	1.47	0.49	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	13.65	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	0.00	0.00	2.10	1.40	1.40	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	15.39	0.00	0.94	2.83	0.79	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	422.47	3.30	6.60	0.00	41.26	8.25	4.95	0.00
Eosinophils, donor3	12246-129H5	356.68	0.00	0.00	0.00	24.97	0.00	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	19.55	1.22	0.49	1.95	0.24	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	0.00	0.00	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	31.20	7.80	1.64	3.69	2.87	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.96	2.74	1.86	1.42	1.53	0.44	0.33	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.67	8.56	3.90	2.06	2.06	1.52	1.84	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.38	12.49	7.52	1.21	5.94	1.58	0.49	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	44.08	12.83	3.68	10.24	2.32	1.36	2.18	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.80	6.86	2.21	2.53	2.43	0.53	1.58	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	48.48	6.06	4.22	6.85	2.11	1.58	1.05	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.87	7.97	6.64	4.65	2.33	0.66	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	21.77	2.27	7.26	4.08	3.18	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	17.43	0.76	0.76	3.03	0.76	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.19	3.15	3.94	1.10	1.42	1.42	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	83.05	17.88	8.18	6.37	5.76	3.03	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	40.36	7.11	2.28	3.93	3.55	0.89	0.63	0.63
Fibroblast - Cardiac, donor6	11460-119B2	38.81	3.18	2.88	3.49	2.27	0.30	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.71	0.27	0.80	2.81	1.07	0.54	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	29.34	3.45	3.02	2.16	3.02	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	0.00	7.32	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	23.99	1.15	1.38	4.38	0.23	0.46	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	69.71	17.47	6.44	2.37	3.22	2.20	3.56	0.17
Fibroblast - Dermal, donor1	11269-116G9	17.61	0.94	1.41	1.64	1.41	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	15.09	0.94	0.00	0.94	0.00	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.48	2.90	0.85	2.66	2.18	0.48	0.12	0.24
Fibroblast - Dermal, donor4	11450-119A1	29.39	1.24	3.73	5.99	2.60	0.79	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	29.66	0.70	2.79	5.23	1.40	0.35	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	29.89	0.65	1.62	3.90	1.14	0.00	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	28.11	6.04	3.96	7.08	1.46	1.25	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	48.21	13.10	5.76	4.45	4.45	1.83	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	20.16	2.24	3.43	5.93	1.19	0.53	0.53	0.00
Fibroblast - Gingival, donor3	11394-118C8	66.81	6.09	4.16	5.41	5.41	0.58	0.97	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	64.41	8.31	2.08	3.12	10.39	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.47	2.64	1.76	2.64	3.52	0.70	0.18	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	51.45	8.57	4.21	3.90	4.83	0.31	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.24	5.00	4.19	5.54	3.11	0.54	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	29.99	1.76	1.41	1.06	2.12	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.22	5.26	4.97	4.39	2.19	0.58	0.73	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	35.04	11.86	6.14	2.59	2.32	0.82	0.55	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.62	2.74	2.85	3.07	3.84	0.22	0.00	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.72	14.82	7.34	5.43	10.12	0.88	0.88	0.00
Fibroblast - Lung, donor1	11270-116H1	9.52	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	1.49	5.97	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	28.49	1.69	1.48	0.63	1.69	0.21	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	0.00	0.00	3.33	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	0.00	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.16	0.00	0.28	0.28	0.00	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	21.52	1.62	0.41	2.44	1.62	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.31	2.72	3.88	6.40	2.13	0.58	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.89	2.12	2.88	7.13	1.37	0.91	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.26	4.90	2.75	9.79	1.53	0.61	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.64	4.96	2.67	3.43	2.29	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.72	2.97	1.35	2.97	2.16	0.27	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.34	3.83	1.16	3.02	4.18	0.23	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	35.81	9.06	3.87	1.99	4.20	0.55	0.55	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.22	0.61	0.61	1.22	0.81	0.20	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	0.00	0.00	4.01	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	23.72	3.56	2.37	1.19	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	39.09	2.58	3.57	9.33	1.39	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	33.93	6.39	3.73	4.97	2.49	0.53	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.57	6.11	2.37	2.17	4.34	0.39	0.79	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	1.81	4.21	2.41	0.60	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	44.91	5.83	7.23	3.78	3.78	1.62	1.84	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	52.89	4.05	3.04	4.30	1.27	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	39.38	4.27	3.61	3.12	3.61	0.16	0.98	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	39.50	5.01	3.81	3.61	1.60	0.60	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	40.59	3.52	5.02	2.91	3.21	0.80	0.30	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.54	3.93	5.44	10.28	0.00	0.60	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	36.78	9.44	4.72	4.64	2.98	0.91	0.50	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	68.89	9.23	9.06	3.76	6.84	2.39	4.10	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	33.83	5.91	4.27	4.27	0.99	1.31	1.64	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.81	4.05	5.11	2.66	1.81	1.28	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	22.94	1.69	2.19	1.69	1.18	0.34	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.41	7.53	5.33	3.61	2.51	1.25	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	44.32	22.16	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	15.69	3.49	4.36	12.20	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	56.17	3.81	2.60	0.52	5.72	0.87	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	76.51	4.68	1.56	1.82	7.03	1.56	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	70.27	7.15	1.79	2.30	4.09	0.51	0.26	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	4.59	0.00	0.00	3.83	1.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	0.00	0.64	0.64	1.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	15.69	0.29	2.00	8.27	1.71	0.86	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	8.27	0.55	1.93	19.85	1.65	1.10	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.68	0.68	1.83	10.05	1.37	0.91	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.07	1.19	0.20	6.54	1.19	0.59	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	7.93	0.79	1.06	21.15	1.32	1.59	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.05	0.33	1.63	16.96	1.30	1.30	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	17.25	2.65	1.77	7.96	0.88	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	15.69	0.57	1.13	4.38	0.42	0.28	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	16.38	0.74	1.72	4.06	0.99	1.97	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.65	0.54	0.54	3.22	1.07	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	27.01	0.74	1.36	3.72	2.35	0.50	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.64	0.42	0.97	5.40	0.69	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.79	0.61	0.81	2.85	1.42	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	20.76	0.23	2.28	3.88	1.37	0.91	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.67	0.75	1.49	4.86	1.74	1.12	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.48	0.44	1.09	4.15	1.53	0.87	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.46	1.18	5.32	3.25	2.07	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.23	1.11	2.23	5.72	1.27	1.91	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.45	0.67	1.79	3.57	2.01	0.67	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	16.13	1.61	2.22	4.23	1.21	1.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.70	1.53	2.88	4.07	2.04	1.36	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	30.77	2.66	4.43	4.17	2.48	2.13	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.07	3.33	7.60	5.10	3.02	5.20	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.08	2.56	7.00	3.42	2.39	4.44	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.25	1.33	3.10	5.31	1.44	1.44	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.38	2.83	4.74	5.91	2.08	2.41	0.08	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.71	1.43	4.29	4.49	0.82	1.84	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.25	1.44	4.13	3.51	1.03	3.30	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.21	2.31	4.73	6.23	1.61	1.96	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.01	3.00	2.17	3.84	2.00	1.17	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.31	1.54	4.41	3.31	0.66	2.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.26	2.58	5.04	6.40	2.21	2.95	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.75	1.78	2.59	5.35	1.62	2.43	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.98	3.85	6.41	6.41	1.28	3.85	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.67	0.85	3.41	4.83	0.66	1.61	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.18	1.58	2.85	4.27	0.63	0.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.16	3.34	3.34	2.13	2.74	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.34	1.57	3.66	4.39	1.46	1.78	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.59	2.85	4.39	5.49	1.32	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.64	1.12	3.09	4.77	1.96	1.68	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.76	2.22	3.98	2.50	1.94	1.76	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.26	2.94	5.35	3.48	1.34	1.07	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.10	1.84	3.83	2.30	1.38	0.61	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.52	1.42	2.33	2.98	1.30	0.52	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.94	1.36	4.34	3.80	2.44	1.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.17	2.03	5.16	3.32	1.29	2.95	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.74	3.29	6.58	2.85	1.75	2.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	1.98	10.91	4.96	2.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.27	1.71	3.83	2.11	1.32	1.58	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.99	3.03	2.22	2.82	0.81	1.01	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	51.85	9.15	27.45	4.83	3.05	13.47	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	24.88	0.60	1.39	1.39	1.39	0.60	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.11	0.15	0.77	4.62	0.77	0.31	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	18.82	0.20	0.20	4.30	1.64	0.20	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.01	0.31	0.31	2.19	0.63	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.32	0.00	0.28	3.11	0.85	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.53	0.00	0.46	11.07	1.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	0.00	0.00	4.95	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.15	0.39	1.55	3.09	1.93	1.16	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	0.00	0.00	4.81	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	0.00	1.74	6.96	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.46	0.00	0.65	3.91	1.63	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.06	0.00	1.24	3.29	0.82	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	0.00	6.66	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.14	0.28	0.84	7.27	0.84	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.69	0.00	0.00	4.25	3.60	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	8.39	0.00	2.52	15.94	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.72	0.32	0.64	8.27	2.23	0.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.23	0.34	1.02	5.09	0.68	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	0.00	0.00	10.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.04	0.00	2.29	5.15	1.72	1.15	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.36	0.30	0.59	6.51	1.48	0.30	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	0.00	0.00	1.69	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	0.00	0.41	10.36	2.07	2.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	10.82	0.00	1.38	7.82	0.46	0.92	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	10.54	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	0.00	1.92	3.84	1.92	2.69	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.25	0.33	2.61	9.45	1.30	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	0.00	1.34	11.37	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.11	0.77	2.31	8.86	1.93	2.31	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.41	1.03	1.37	6.16	3.42	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	0.00	2.48	19.88	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	13.21	0.00	3.30	13.21	1.42	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.90	1.81	2.41	7.24	0.00	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	1.53	3.05	13.73	2.54	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.97	0.80	2.39	13.56	3.59	0.80	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.32	0.49	5.43	8.39	1.97	5.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	1.18	1.18	4.72	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.75	0.00	2.33	9.34	0.00	2.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.02	1.32	2.63	7.46	2.63	2.19	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	3.39	3.39	7.63	0.85	2.54	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.71	0.00	1.19	6.57	1.19	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	1.46	4.37	6.79	2.91	1.46	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	2.28	1.14	1.14	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	1.66	2.49	1.66	2.49	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.96	5.39	3.49	0.63	1.27	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.55	4.18	2.92	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.37	23.32	5.92	3.02	6.61	3.37	0.93	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	71.74	21.61	3.38	2.36	4.39	1.69	1.52	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	60.97	12.51	3.64	2.50	5.01	1.14	1.37	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	68.32	21.10	5.25	2.40	4.70	2.30	0.77	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.29	17.19	3.44	3.44	3.87	0.86	1.29	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	66.74	12.49	3.23	2.58	4.31	1.72	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.83	15.94	3.11	3.86	4.11	1.37	1.00	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	46.83	15.61	3.95	2.23	3.09	1.03	0.69	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.68	10.57	1.28	2.56	2.56	2.24	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.28	0.00	1.68	2.80	1.12	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.00	0.00	1.30	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	0.00	2.64	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	0.00	0.71	2.12	0.35	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	0.73	0.73	0.73	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.62	5.77	3.85	1.92	1.22	0.87	0.17	0.00
Hepatocyte, donor1	11523-119I2	18.16	4.84	1.21	7.26	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	3.23	1.08	4.31	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	36.81	4.29	3.07	6.75	1.84	4.91	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	17.62	0.00	1.96	18.28	0.65	3.26	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	52.61	3.85	2.10	6.29	4.72	0.52	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.40	1.51	2.74	1.37	0.82	0.69	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	12.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	0.00	0.00	5.54	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	0.00	7.51	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	4.57	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	0.00	1.67	6.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	3.63	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	0.00	1.32	9.26	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	0.00	0.00	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.12	0.00	0.00	4.41	2.52	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	0.00	0.00	1.29	0.65	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	0.00	0.00	4.83	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	23.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.82	0.00	0.00	3.26	0.81	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.85	0.00	0.42	3.36	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	0.00	0.00	3.21	1.61	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	0.00	0.00	2.83	1.89	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	0.00	0.00	2.72	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	0.00	1.08	2.15	4.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	0.00	0.00	1.27	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.75	0.00	0.00	2.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	0.00	0.00	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	8.57	0.00	0.00	4.28	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.88	0.00	0.00	2.16	0.62	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	0.00	0.00	1.76	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	6.29	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	17.38	0.00	0.00	3.48	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	0.00	2.21	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	0.00	0.00	6.98	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	0.00	0.00	6.75	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	25.60	1.07	0.00	7.47	1.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	0.00	0.00	1.39	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	0.00	0.00	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00	9.08	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	18.63	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	0.00	0.00	8.46	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	33.95	1.39	0.33	1.71	4.24	0.08	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	26.94	0.00	0.59	1.76	1.76	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	49.79	1.89	0.76	1.61	2.56	0.38	0.57	0.09
Keratinocyte - oral, donor1	11251-116E9	78.33	34.51	11.58	2.72	7.83	4.20	1.36	0.34
Keratocytes, donor1	11527-119I6	20.63	0.34	0.00	1.38	0.69	0.00	1.03	0.00
Keratocytes, donor2	11607-120I5	18.75	1.17	0.00	1.17	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	65.01	11.46	2.17	0.59	7.90	0.59	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	8.79	13.19	0.00	4.40	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	1.08	3.24	2.16	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.95	5.07	10.26	4.15	0.46	7.50	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	40.46	4.44	8.68	1.61	2.72	2.83	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.34	4.98	1.42	1.78	1.07	0.71	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.63	3.35	0.56	2.23	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	40.30	9.76	3.94	3.15	1.89	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.21	3.76	3.23	2.69	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.96	2.21	0.00	1.26	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.46	2.26	0.86	1.08	0.43	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.50	7.39	2.05	1.64	1.64	0.82	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.83	1.52	0.51	1.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.95	3.80	0.99	1.41	0.99	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.27	5.54	3.16	0.79	2.37	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	31.41	4.46	1.94	0.97	0.97	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.44	1.11	0.19	0.93	0.56	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	24.04	4.53	1.39	2.09	3.14	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.56	2.62	0.72	1.67	1.67	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.05	2.75	0.55	2.20	1.65	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	38.19	9.85	1.85	0.92	1.23	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.47	1.25	0.00	0.94	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.01	3.11	1.10	1.46	1.10	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	24.68	5.59	1.97	2.96	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	11.42	0.59	0.59	0.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	1.24	0.75	1.00	0.75	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	4.85	3.39	1.94	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.89	3.23	2.15	0.27	1.62	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.14	3.78	2.12	1.97	1.21	0.00	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.66	3.63	0.52	2.59	1.56	0.52	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	35.39	5.86	2.09	1.05	2.30	1.26	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.34	2.71	1.65	1.50	1.05	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	1.38	2.06	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.66	4.33	1.32	0.75	1.13	0.19	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.41	1.48	0.64	1.38	0.64	0.32	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.53	4.85	2.91	1.94	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.18	2.98	0.99	0.33	1.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.63	1.98	0.99	1.24	0.12	0.25	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.47	6.66	2.22	2.22	1.85	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.17	4.45	1.98	0.74	0.74	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.86	1.37	0.69	1.10	0.41	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.70	5.15	2.57	0.96	2.57	0.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	40.78	8.22	1.83	0.61	1.22	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.41	6.72	2.38	2.10	0.84	0.84	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.87	8.53	1.42	2.49	1.78	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	1.45	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.80	1.71	0.93	1.09	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.22	2.86	0.36	3.58	1.79	1.07	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.50	3.92	0.33	1.63	0.33	0.33	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	0.71	1.18	0.71	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.06	4.83	2.85	3.22	0.99	0.62	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.09	0.51	0.77	0.77	0.51	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	16.71	1.49	1.79	1.19	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	2.27	2.27	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	0.00	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	0.00	2.23	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.58	1.27	0.85	0.00	0.85	0.42	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.70	0.70	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	0.00	0.93	0.00	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	0.52	1.03	0.00	0.52	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	1.19	0.00	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.35	0.45	1.81	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.90	1.16	2.04	0.00	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.16	2.25	4.05	0.00	1.35	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.04	0.95	1.49	0.00	1.35	0.68	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	1.03	0.51	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.99	1.06	1.76	0.00	0.35	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	10.66	2.00	0.67	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	10.19	0.51	1.02	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.61	2.13	2.40	0.00	0.53	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.76	2.46	1.51	0.00	0.76	0.76	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.73	0.61	1.84	0.00	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	4.08	0.82	0.00	1.63	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.57	1.67	2.08	0.00	0.83	0.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.34	1.40	0.56	0.00	1.40	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	19.58	3.09	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.06	1.16	1.74	0.00	0.58	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	18.83	1.20	1.79	0.00	2.09	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.68	2.21	1.11	0.00	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.61	1.06	0.71	0.00	1.41	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.44	0.37	1.11	0.00	2.95	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	0.00	0.00	0.00	2.30	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	0.00	0.00	0.00	1.92	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	0.00	1.13	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	2.46	0.00	0.00	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	1.81	2.26	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	0.00	0.72	0.00	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.19	0.00	0.00	0.00	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.01	1.11	1.49	0.00	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.65	0.86	0.43	0.00	0.86	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	0.86	0.00	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.99	0.33	1.67	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	0.60	0.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	1.42	1.42	0.00	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	16.15	0.69	1.03	0.00	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.81	0.00	0.54	0.00	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	2.02	1.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.48	0.37	1.11	0.00	1.48	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	0.00	2.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	1.06	1.06	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.01	0.80	1.60	0.00	2.00	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	0.00	0.73	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	0.00	0.77	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	10.36	1.97	0.99	0.00	1.97	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	0.00	0.00	0.00	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	0.00	0.50	0.00	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	0.90	0.45	0.00	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	1.72	1.72	0.00	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.81	0.00	1.34	0.00	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	1.56	1.17	0.00	1.17	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	0.00	3.96	0.00	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	2.08	0.52	0.00	1.56	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.63	0.44	2.63	0.00	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	1.12	1.68	0.00	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.29	0.00	0.88	0.00	2.21	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	21.60	0.39	1.16	0.00	0.77	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	1.01	0.51	0.00	2.53	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.47	0.96	0.96	0.00	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.07	0.00	1.59	0.00	1.99	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	0.61	1.22	0.00	1.22	0.61	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	14.53	0.00	0.00	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.80	1.14	1.14	0.00	1.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.56	1.03	0.52	0.00	3.10	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	0.00	0.60	0.00	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	0.32	0.63	0.00	1.90	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	1.60	1.07	0.00	4.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	0.00	0.51	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	0.71	0.00	0.00	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.13	0.57	0.00	0.00	2.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.71	0.00	0.83	0.00	0.00	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	0.00	0.78	0.00	1.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	0.42	0.84	0.00	0.42	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.80	0.00	0.46	0.00	2.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	0.00	0.00	0.00	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.18	0.53	0.53	0.00	2.14	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	0.00	0.40	0.00	3.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	0.00	0.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	0.00	0.00	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	1.14	0.57	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	0.00	0.00	0.00	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	0.55	0.55	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.71	0.00	0.89	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.20	0.78	0.78	0.00	0.78	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.90	0.00	1.33	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	75.90	12.76	12.31	9.80	6.84	3.65	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	80.01	4.04	7.52	7.89	13.76	3.30	1.10	0.55
Macrophage - monocyte derived, donor3	11389-118C3	60.95	2.75	3.54	8.00	5.77	1.84	0.39	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	56.29	2.66	1.59	0.53	1.59	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	48.33	3.64	2.85	1.11	5.07	0.95	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	52.54	4.73	1.11	2.22	3.20	1.39	0.28	0.28
Mammary Epithelial Cell, donor1	11273-116H4	64.77	26.41	9.07	4.68	9.37	2.19	2.19	0.20
Mammary Epithelial Cell, donor2	11350-117G9	60.52	7.53	3.19	2.90	4.63	0.58	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	20.20	0.50	0.00	0.25	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	127.45	6.78	52.88	17.63	63.05	25.76	2.03	2.71
Mast cell, donor1	11563-120D6	37.31	2.49	48.99	6.60	5.84	31.04	0.11	0.22
Mast cell, donor2	11565-120D8	113.22	11.29	41.60	6.54	13.37	57.35	0.89	0.30
Mast cell, donor3	11566-120D9	99.51	13.51	49.53	8.55	14.86	63.26	1.13	0.68
Mast cell, donor4	11567-120E1	116.66	2.66	28.72	7.98	23.40	62.58	1.42	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	29.72	2.77	23.51	15.19	4.10	15.86	0.22	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	3.50	33.27	11.67	11.67	8.76	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	26.50	1.15	24.89	11.13	3.90	26.50	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	17.07	1.67	29.79	13.39	3.68	20.75	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	40.20	4.68	5.17	2.09	1.69	0.99	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	39.80	11.42	4.15	1.04	2.77	1.04	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	54.11	2.54	3.84	7.32	3.62	1.09	0.36	0.14
Melanocyte - light, donor1	11274-116H5	11.99	1.18	0.71	2.12	1.65	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	0.00	1.36	0.68	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	10.41	0.87	0.87	1.73	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	41.13	2.29	2.19	3.96	1.98	0.62	0.21	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	25.28	1.08	1.88	2.42	2.42	1.08	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	39.91	7.23	9.11	4.55	2.68	2.41	0.54	0.27
Meningeal Cells, donor1	11493-119E8	12.90	0.25	0.25	3.60	0.37	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	7.48	0.00	0.88	6.16	0.00	0.44	0.00	0.44
Meningeal Cells, donor3	11654-122E7	24.53	2.45	3.99	1.96	1.30	0.41	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	34.50	8.55	9.12	2.00	0.29	1.43	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.75	11.07	7.25	2.31	5.64	3.02	0.91	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	0.00	0.00	1.31	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	1.31	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	1.44	0.72	1.44	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.42	5.08	1.91	2.75	2.33	0.64	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.12	3.02	2.01	0.50	2.01	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.65	1.32	1.10	1.32	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	0.00	0.73	5.11	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.98	0.61	0.41	2.25	0.41	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.24	4.16	10.67	2.91	2.08	3.46	1.11	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.98	0.37	0.37	1.12	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.95	13.68	6.84	3.16	4.21	1.97	0.53	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	0.59	1.48	0.59	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	1.28	0.00	1.92	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	32.61	1.42	1.77	2.13	1.06	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.85	12.51	3.75	3.75	4.38	0.94	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	5.08	1.45	2.90	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	28.90	9.81	7.42	2.39	5.04	2.39	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	30.03	6.51	2.50	1.00	1.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	35.27	9.11	5.35	2.89	2.46	1.66	1.52	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	2.70	1.35	5.40	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	61.57	3.69	6.90	3.20	6.16	1.97	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	39.16	0.88	2.65	4.71	7.07	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	3.46	0.00	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	50.83	9.61	6.51	2.17	6.20	2.48	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	38.58	2.07	2.49	3.32	6.43	0.83	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	2.32	2.32	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	70.32	8.01	3.75	3.75	9.76	3.00	1.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	53.53	1.86	1.40	4.65	6.52	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	92.67	6.71	4.67	2.85	10.36	1.42	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	83.55	2.38	2.77	4.36	9.50	0.79	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	8.55	25.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	100.88	7.08	2.65	0.88	8.85	4.42	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	85.11	3.80	3.04	2.66	9.88	1.14	1.14	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	115.80	1.32	0.00	1.32	6.58	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	151.10	11.25	3.61	2.55	18.89	1.49	0.64	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	65.38	0.00	0.00	2.76	6.45	1.84	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	175.26	2.98	1.49	1.79	16.39	0.60	0.60	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	48.62	0.00	0.00	1.68	8.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	128.46	7.78	0.50	1.51	17.56	0.50	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	95.78	7.61	2.85	2.38	15.92	1.66	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	87.91	0.55	0.00	0.55	13.27	0.55	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	81.51	6.68	1.61	0.46	9.67	1.38	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	98.86	6.94	1.68	1.26	19.98	1.05	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	98.86	6.93	1.83	1.63	11.41	1.83	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	65.65	7.94	3.00	1.93	9.01	0.00	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	77.58	4.00	1.78	2.00	14.23	1.11	0.89	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	63.95	3.29	1.31	1.31	10.51	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	66.41	1.52	1.01	1.01	10.65	0.00	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	39.77	0.00	0.00	0.00	3.31	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	80.18	2.17	1.09	0.82	13.05	0.54	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	75.29	2.94	0.59	1.47	12.06	1.76	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	38.16	0.00	1.09	2.18	3.27	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	57.19	4.32	1.92	0.96	8.17	1.44	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	70.04	5.20	2.80	2.40	14.01	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	60.33	1.37	0.00	4.11	5.48	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	66.58	3.00	1.50	1.50	10.01	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	2.04	0.00	0.00	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	73.13	3.07	0.44	2.63	5.69	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	55.18	2.21	0.00	3.31	5.52	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	65.96	2.56	0.00	1.28	7.68	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	68.92	9.42	1.98	0.25	6.69	0.99	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	48.02	0.00	2.09	0.70	6.96	2.09	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	0.00	0.00	0.00	6.63	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	60.17	11.62	1.71	1.03	10.60	2.74	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	54.70	1.31	0.00	0.88	8.75	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	50.78	3.20	0.71	1.78	3.55	0.36	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	69.30	10.10	1.40	2.24	8.98	1.12	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	74.40	1.25	2.08	2.49	8.31	0.83	0.00	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	70.51	0.00	0.58	3.50	3.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	65.16	6.33	1.21	0.60	8.14	1.21	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	81.81	2.92	3.34	2.92	5.01	1.67	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	68.34	6.46	0.92	0.92	6.46	0.92	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	89.35	2.85	1.71	2.85	10.24	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	77.52	7.46	0.97	1.38	8.84	0.55	0.41	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	71.78	10.11	1.04	2.33	5.96	1.30	0.00	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	73.78	3.86	1.29	2.57	6.01	0.86	0.86	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	61.61	1.91	0.00	0.00	6.35	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	74.46	6.14	1.60	2.14	10.68	0.27	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	85.91	9.88	6.59	2.39	11.37	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	75.71	4.10	0.85	1.55	9.61	1.27	0.00	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	61.15	9.87	1.59	0.32	7.01	1.27	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	93.76	8.62	1.99	3.54	11.06	0.44	0.22	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	78.87	5.31	0.38	0.00	6.83	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	77.85	15.34	2.56	1.99	12.78	1.14	1.42	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	93.16	11.80	1.97	2.46	9.83	2.21	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	58.65	3.26	1.96	2.61	11.73	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	90.27	14.70	2.65	1.47	13.82	0.88	0.00	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	102.07	12.40	2.59	2.02	11.24	1.73	0.86	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	111.69	5.77	4.12	1.65	17.31	4.53	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	91.12	12.21	3.28	2.08	13.40	2.08	0.60	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77	3.77	3.77	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	21.39	7.13	3.56	8.91	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	49.61	9.20	6.24	4.27	5.26	2.63	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	8.42	1.05	2.10	4.21	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	69.19	13.44	13.84	6.72	4.15	2.57	1.19	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	83.82	5.59	6.52	4.66	13.97	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	55.58	4.13	6.01	6.01	5.26	1.88	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	46.34	7.72	4.00	4.00	6.13	1.60	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	65.82	9.27	6.22	2.71	4.41	1.47	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	45.68	9.58	5.89	2.95	5.16	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	43.60	7.33	4.76	6.96	6.23	1.47	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	56.00	7.78	4.67	6.22	9.33	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	94.06	23.52	6.95	2.67	9.62	2.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	3.86	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	55.55	6.06	7.07	3.03	3.03	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	54.39	11.81	3.79	0.84	3.79	0.84	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	51.75	65.37	9.53	0.00	6.81	1.36	5.45	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.07	15.26	5.72	0.64	3.18	0.00	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.91	17.82	1.62	1.62	3.24	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	22.66	0.00	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	228.41	125.62	0.00	5.71	39.97	0.00	39.97	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	94.61	137.02	75.04	9.79	16.31	19.57	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	33.27	4.75	0.00	23.76	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	37.65	12.55	0.00	12.55	0.00	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.65	3.02	3.88	2.80	1.72	1.29	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	7.84	5.23	1.05	2.61	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	2.00	2.00	2.67	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	1.67	0.83	1.67	0.83	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.84	5.32	4.75	4.94	1.71	1.14	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	3.19	6.38	3.19	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	0.68	0.68	2.72	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	9.19	11.03	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	2.93	2.09	2.09	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.81	3.25	3.02	2.56	0.70	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.35	4.05	4.32	1.35	1.08	0.54	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.65	4.63	3.99	2.10	2.52	0.42	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	55.67	0.00	0.00	11.13	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.39	5.96	3.47	0.99	1.49	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.31	5.68	2.44	1.62	1.35	0.27	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.93	2.72	2.95	1.36	1.36	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.80	1.14	1.63	0.82	0.98	0.82	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.25	7.11	5.10	2.00	2.55	0.73	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	9.02	3.71	1.59	0.53	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	9.00	2.40	1.80	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.81	19.69	12.47	8.20	2.30	0.66	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.13	3.74	1.95	1.63	1.95	0.33	1.30	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.45	5.29	2.12	2.29	2.12	0.35	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	3.52	4.22	0.00	2.11	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	5.52	0.00	1.84	0.92	1.84	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	1.93	3.86	1.29	3.21	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.35	22.07	9.66	6.90	3.10	3.10	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	83.44	17.70	37.93	5.06	10.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.62	1.78	2.23	3.56	2.90	0.45	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	5.08	2.12	1.27	2.54	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.65	11.39	4.75	2.37	1.42	0.71	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.17	6.01	2.15	5.15	1.29	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	126.39	90.28	9.03	9.03	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	18.66	1.67	2.67	2.33	2.33	0.00	1.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.94	1.80	1.80	1.35	0.90	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.52	3.17	3.97	0.40	1.59	0.40	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	3.71	4.64	0.93	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.16	6.81	8.32	3.03	1.89	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	4.24	2.61	2.61	3.26	0.98	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.92	3.49	3.05	1.74	0.00	0.44	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.52	2.26	4.52	2.71	1.81	1.81	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	6.17	5.29	0.88	1.76	1.76	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	6.65	0.66	1.33	4.65	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.80	1.98	2.98	3.47	0.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	3.06	4.98	1.91	6.13	1.53	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.92	5.44	5.75	3.63	3.02	0.91	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.43	3.98	3.54	1.77	1.99	0.66	0.22	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	3.39	6.10	2.03	4.07	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	56.20	35.77	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	4.88	5.49	3.05	1.83	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.31	3.46	2.83	5.35	2.52	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.38	1.82	2.42	2.12	1.21	0.30	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	2.37	5.54	6.33	2.37	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	23.81	9.07	4.53	5.67	6.80	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	40.46	15.17	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	24.47	7.58	2.24	3.48	1.49	0.37	0.25	0.37
Myoblast, donor2	11322-117D8	36.82	6.14	2.49	4.79	2.88	0.96	0.58	0.00
Myoblast, donor3	11398-118D3	40.70	5.89	4.20	5.21	2.35	0.50	0.34	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	43.93	3.21	7.44	11.97	5.40	1.02	0.73	0.15
Natural Killer Cells, donor1	11230-116C6	45.51	9.53	9.53	4.92	13.84	10.76	7.38	0.31
Natural Killer Cells, donor2	11311-117C6	36.49	3.02	5.13	5.13	10.55	4.52	3.62	0.00
Natural Killer Cells, donor3	11387-118C1	44.73	7.55	9.39	3.50	14.17	5.71	5.89	0.37
Neural stem cells, donor1	11275-116H6	47.55	9.07	10.89	1.45	7.26	8.35	0.36	0.73
Neural stem cells, donor2	11352-117H2	48.14	3.85	5.78	3.85	1.93	5.78	0.00	1.93
Neurons, donor1	11494-119E9	34.14	3.41	6.83	1.14	1.14	4.55	0.00	0.00
Neurons, donor2	11574-120E8	18.71	3.08	6.83	3.30	1.76	3.96	0.44	0.00
Neurons, donor3	11655-122E8	20.55	2.47	5.76	0.82	5.76	2.47	0.00	0.82
Neutrophils, donor1	11233-116C9	195.81	2.78	0.00	0.93	27.84	0.93	2.78	0.00
Neutrophils, donor2	11314-117C9	153.64	2.90	0.00	0.00	2.90	2.90	5.80	0.00
Neutrophils, donor3	11390-118C4	354.90	4.28	3.05	0.00	37.87	3.05	4.28	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	60.08	25.88	12.82	2.37	4.27	1.90	2.37	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	28.33	3.91	4.56	0.98	2.28	0.00	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	28.28	2.61	1.40	0.60	1.00	0.40	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	24.09	7.30	1.79	3.03	3.30	0.41	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	27.36	10.42	6.37	3.47	2.61	1.01	0.72	0.43
Olfactory epithelial cells, donor3	11935-125I9	26.67	6.02	2.84	3.86	2.72	0.23	0.68	0.00
Olfactory epithelial cells, donor4	11936-126A1	36.04	7.60	4.87	2.24	2.53	0.78	0.39	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	60.78	3.61	7.22	4.21	4.81	3.01	3.01	0.00
Osteoblast - differentiated, donor1	11276-116H7	24.46	2.55	1.91	1.49	2.98	1.28	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	33.15	0.00	1.14	0.00	5.72	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	36.00	3.72	1.24	0.00	3.72	0.62	1.24	0.62
Osteoblast, donor1	11277-116H8	9.19	0.00	0.59	0.98	0.98	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	29.50	4.21	10.53	3.51	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	22.39	2.31	0.53	1.07	0.89	0.71	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	26.28	6.57	4.63	2.27	2.27	0.51	0.76	0.17
Pericytes, donor1	11491-119E6	7.68	0.22	0.45	0.78	0.45	0.45	0.22	0.00
Pericytes, donor2	11571-120E5	6.56	0.23	0.68	1.81	0.45	0.23	0.45	0.00
Pericytes, donor3	11652-122E5	9.16	0.41	1.63	3.05	0.00	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	35.60	4.97	5.31	1.92	1.36	1.81	0.79	0.11
Perineurial Cells, donor2	11579-120F4	58.98	19.51	7.91	1.75	4.78	2.30	0.74	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.22	5.42	7.65	6.06	6.37	5.42	2.55	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	38.20	2.94	1.71	4.41	5.63	1.96	1.71	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	54.23	3.75	2.85	3.36	6.08	2.98	1.29	0.26
Placental Epithelial Cells, donor1	11278-116H9	17.22	0.24	0.00	0.00	0.48	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	11.09	2.22	2.22	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.39	1.37	1.37	0.20	1.18	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.00	3.48	2.22	1.27	3.48	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	39.39	9.00	5.25	1.88	5.06	0.94	1.31	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.87	10.57	2.09	3.65	1.96	0.39	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	32.87	5.40	2.70	3.15	0.90	0.45	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	48.48	14.17	4.37	2.56	5.86	1.07	1.92	0.32
Preadipocyte - omental, donor2	11329-117E6	75.95	13.53	6.55	2.18	6.55	1.31	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	40.11	9.17	3.15	1.86	2.44	0.29	1.43	0.29
Preadipocyte - perirenal, donor1	11469-119C2	23.62	2.95	0.00	2.95	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.20	1.23	2.15	1.84	1.84	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.99	2.48	1.59	1.42	1.59	0.00	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	30.14	4.60	1.53	0.51	3.75	0.34	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	36.23	6.43	2.89	2.05	2.98	0.28	0.84	0.19
Preadipocyte - visceral, donor2	11357-117H7	28.07	2.76	3.22	2.30	1.38	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	25.39	1.15	1.36	1.88	1.25	0.21	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.37	2.87	2.11	6.49	5.28	0.30	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	44.55	2.30	1.62	1.76	5.55	0.27	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	51.75	3.43	1.65	2.88	4.16	0.86	0.12	0.18
Prostate Stromal Cells, donor1	11254-116F3	70.28	16.97	5.24	2.96	6.38	2.51	1.14	0.46
Prostate Stromal Cells, donor2	11332-117E9	47.69	6.63	2.51	2.69	3.77	0.72	1.08	0.36
Prostate Stromal Cells, donor3	11405-118E1	62.67	10.74	3.65	2.09	7.61	0.83	1.36	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.04	0.36	0.73	1.82	0.73	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.75	3.05	5.20	5.82	2.22	1.39	0.00	0.14
Renal Epithelial Cells, donor1	11517-119H5	7.10	0.00	0.51	1.52	0.51	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	12.80	0.00	0.00	2.85	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	31.87	4.66	7.73	6.67	3.49	2.01	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.49	0.00	0.27	1.62	0.27	0.00	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.53	1.11	2.89	2.44	0.00	0.44	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.00	0.00	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.14	0.00	1.10	1.32	0.22	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.00	0.00	3.13	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.27	0.28	0.28	1.39	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.76	0.27	0.00	3.22	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	0.00	0.42	1.69	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	0.39	0.00	2.51	0.39	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.04	4.15	5.19	4.41	1.56	3.11	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	0.28	0.57	2.56	0.28	1.42	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	43.66	3.76	2.01	5.02	4.77	1.00	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	81.25	10.56	8.95	5.21	4.68	4.81	1.74	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.97	0.00	4.47	7.15	4.47	3.57	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	3.85	6.05	5.50	3.30	1.10	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	10.44	1.16	4.64	9.28	1.74	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	33.94	0.39	3.77	3.77	1.82	1.56	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	26.51	0.79	3.18	2.78	1.49	0.70	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	34.47	1.45	3.90	4.91	2.12	0.89	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.17	1.74	5.33	2.73	1.24	1.36	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.81	1.28	2.56	3.15	0.70	0.70	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.96	1.16	3.93	4.62	2.08	1.62	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.29	0.41	2.88	1.92	0.96	1.10	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.81	1.66	4.54	3.18	1.36	1.51	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.76	1.25	3.58	4.12	2.69	1.25	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	27.83	0.86	2.01	2.73	0.43	0.43	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.79	1.07	3.33	2.25	0.86	0.86	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.88	0.89	2.66	2.21	1.55	0.89	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.51	0.38	2.10	1.91	1.53	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.62	0.93	2.89	2.98	0.93	0.84	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	27.62	1.88	4.32	4.51	2.44	0.94	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.85	0.66	2.12	2.79	0.80	0.93	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	26.67	1.95	3.60	3.21	1.65	1.17	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.49	0.95	3.25	3.25	1.72	1.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.77	0.32	2.67	3.10	0.75	0.64	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	20.74	2.24	3.64	1.40	1.96	0.28	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.17	1.03	3.59	3.25	2.39	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	29.72	0.73	1.28	3.10	2.01	0.55	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	21.46	0.98	3.56	2.33	1.59	0.37	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.00	1.48	3.09	2.69	1.21	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.48	0.00	3.77	1.18	2.36	0.24	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.61	1.59	3.37	3.97	1.39	0.20	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.55	0.94	1.40	3.98	1.17	0.47	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.50	0.62	1.24	2.28	1.24	1.04	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	28.31	1.77	2.88	1.33	2.21	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	0.42	1.88	3.55	1.46	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.74	0.40	2.02	2.83	1.88	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.37	1.87	3.41	3.58	1.87	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	28.15	1.35	1.74	2.70	2.31	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.45	0.34	4.13	2.75	0.34	0.86	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	26.20	0.96	2.74	2.19	1.37	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.55	0.82	3.28	2.96	1.48	0.49	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.27	0.51	3.24	2.22	0.85	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.56	2.22	4.44	2.81	1.92	0.74	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	0.80	3.20	5.06	1.33	1.33	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.56	0.14	2.35	3.73	1.94	0.97	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.00	0.71	2.14	4.52	1.43	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	35.87	0.81	2.22	6.05	1.41	1.41	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.65	0.19	2.83	2.45	1.51	0.66	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.44	2.45	4.54	4.89	3.14	0.35	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.27	2.42	2.42	6.65	2.42	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	25.46	0.49	2.94	3.43	1.84	0.98	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.32	5.82	6.55	20.67	8.15	1.89	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	30.42	3.04	4.26	7.30	1.22	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.91	0.60	3.32	2.41	0.60	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.84	0.90	3.17	4.07	3.17	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	30.85	2.10	4.79	6.59	3.00	1.80	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.67	1.18	4.72	6.14	3.07	0.47	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.61	1.92	2.13	4.70	4.48	0.64	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.04	1.20	2.40	9.62	6.01	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	9.40	0.19	0.00	2.82	0.56	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	0.00	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.77	3.29	1.97	2.19	0.88	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	40.53	3.29	0.55	0.55	2.19	1.10	0.55	0.00
Sebocyte, donor2	11301-117B5	21.14	2.76	0.46	1.38	1.84	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	16.70	2.47	1.24	2.06	0.21	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	29.82	6.63	1.66	6.63	11.60	1.66	1.66	3.31
Sertoli Cells, donor2	11333-117F1	28.24	11.30	0.00	5.65	14.12	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.58	7.57	4.49	2.46	2.90	0.53	0.70	0.26
Skeletal Muscle Cells, donor2	11358-117H8	15.90	0.00	0.00	0.72	2.89	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	0.00	0.00	0.00	0.84	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	29.22	2.04	2.51	2.20	2.20	0.31	0.47	0.47
Skeletal Muscle Cells, donor5	11455-119A6	29.28	2.23	1.49	3.72	1.78	0.15	0.89	0.00
Skeletal Muscle Cells, donor6	11459-119B1	31.40	1.69	1.08	3.69	1.54	0.46	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.90	17.89	7.69	8.69	3.91	0.50	1.01	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.68	4.42	1.43	6.14	2.14	0.14	0.43	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.41	3.47	1.29	5.26	2.88	0.40	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.74	4.97	4.97	1.60	1.85	2.70	0.34	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.92	0.00	0.00	0.72	2.17	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.01	1.24	0.69	0.83	0.69	0.28	0.00	0.14
Skin - palm, donor1	10286-104F7	42.98	8.06	5.37	0.00	13.43	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.58	1.73	1.01	1.15	4.04	0.58	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	5.73	3.27	54.80	4.09	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	32.59	3.64	2.60	1.82	3.12	0.52	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	77.84	15.99	7.09	3.34	12.37	4.87	0.42	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	69.48	7.31	2.53	2.39	9.00	0.56	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	112.28	15.65	7.82	56.03	5.50	4.23	1.06	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	76.75	4.65	1.42	3.60	6.45	0.60	0.37	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.45	2.16	4.94	2.78	1.23	0.93	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.68	2.67	5.56	5.56	2.45	1.11	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	4.70	2.35	1.18	1.76	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.69	1.33	1.99	2.21	1.10	0.66	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.24	1.18	1.18	1.18	1.18	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	2.32	0.77	3.09	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	114.09	36.03	17.01	1.00	6.00	3.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.30	3.06	3.06	0.67	1.60	0.40	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.04	7.98	3.32	0.66	2.88	0.89	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.78	2.43	2.05	5.63	3.33	0.77	0.51	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.37	2.60	3.91	3.58	0.65	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.21	6.20	1.77	3.84	1.77	1.18	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.07	1.00	0.71	4.13	1.42	0.14	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.53	0.00	0.00	0.81	0.00	0.00	0.49	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	53.88	2.74	0.91	3.04	3.04	0.30	2.74	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.91	3.79	0.76	1.01	2.27	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.26	0.00	0.95	2.38	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.10	4.87	2.95	4.13	2.80	0.59	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.47	2.15	2.15	3.66	2.15	0.22	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	31.07	2.20	1.89	3.57	1.36	0.52	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.13	0.46	0.62	1.08	0.93	0.31	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	3.23	0.00	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.14	0.90	0.90	4.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	0.00	0.00	1.71	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	63.06	17.98	8.80	4.08	2.12	2.20	1.81	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.21	4.13	7.35	1.71	5.23	3.12	0.50	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	29.81	10.47	3.19	2.73	1.82	0.00	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	0.60	1.21	3.62	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.54	9.01	3.71	1.85	1.32	0.53	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	62.32	6.66	5.19	1.86	4.39	2.00	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	93.41	13.27	3.88	3.01	8.64	1.63	1.38	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.89	7.10	1.01	1.27	4.31	1.01	2.03	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.35	5.58	3.62	1.66	1.51	0.90	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	1.50	0.75	3.00	1.50	0.00	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	0.00	3.88	2.58	0.00	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.07	4.19	1.86	0.93	1.86	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.75	4.54	2.52	0.00	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	27.89	3.13	3.13	2.19	2.19	0.63	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	0.59	0.00	0.88	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.82	7.66	3.33	2.83	1.67	0.58	0.50	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.10	4.67	1.87	1.40	1.87	1.40	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.96	1.15	1.30	1.15	0.58	0.58	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	2.04	1.78	1.27	0.76	1.02	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.78	0.94	0.56	1.32	1.13	0.00	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.50	8.52	7.41	3.07	0.98	1.54	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	50.78	5.45	3.44	2.93	2.60	0.84	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	1.22	1.47	0.49	1.47	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.26	2.87	3.54	1.33	5.30	1.55	0.88	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.35	4.68	4.68	0.29	2.93	0.88	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	34.60	11.47	4.28	3.11	6.22	0.58	2.53	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	3.97	1.32	0.53	1.59	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.24	30.13	9.30	2.98	6.70	2.23	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.76	5.39	2.16	2.16	5.75	0.00	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.60	4.26	1.70	2.56	1.70	0.57	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.18	3.54	1.97	2.36	1.18	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	34.28	16.51	5.59	3.30	7.87	1.02	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	29.15	13.98	4.39	1.20	4.39	1.20	3.19	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	27.17	6.27	1.25	1.25	5.85	0.84	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.50	11.92	4.58	0.92	6.88	1.83	3.21	0.46
Synoviocyte, donor1	11291-117A4	47.30	8.08	2.69	2.52	11.28	1.01	0.50	0.17
Synoviocyte, donor2	11368-117I9	55.48	15.42	1.84	3.52	3.69	0.34	1.84	0.34
Synoviocyte, donor3	11440-118H9	33.73	6.03	1.79	5.36	2.68	0.22	1.34	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	12.15	0.36	0.36	3.57	0.71	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	3.96	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.47	2.78	0.93	1.62	1.39	0.23	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	33.33	4.01	1.79	1.51	3.66	0.65	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	19.71	0.39	0.77	2.32	1.93	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	19.47	1.15	1.15	1.72	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.51	10.83	10.58	3.94	5.91	3.81	2.58	0.37
Urethra, donor2	10319-105A4	48.56	1.80	17.98	12.59	5.40	7.19	1.80	1.80
Urothelial Cells, donor1	11520-119H8	14.61	0.27	0.00	1.59	0.53	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	16.82	0.80	0.40	2.00	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	17.19	0.23	0.92	0.46	0.46	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	61.30	10.03	6.46	4.24	3.57	0.89	0.22	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	90.76	0.00	12.46	4.45	6.23	19.58	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	101.50	0.00	14.30	10.01	7.15	27.16	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	61.61	0.00	3.42	4.79	1.37	6.16	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	43.73	1.03	6.54	6.89	4.13	16.18	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	33.70	0.58	8.72	5.81	4.07	15.11	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	0.00	4.16	3.12	8.33	13.54	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	94.53	0.00	11.01	5.51	3.67	15.60	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	37.43	0.91	2.74	5.48	1.83	7.30	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	30.72	0.74	1.48	8.02	2.84	1.60	0.99	0.37
Wilms' tumor cell line:HFWT	10597-108E3	55.44	3.52	0.88	6.16	3.52	3.52	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	107.82	19.83	7.26	8.66	9.50	1.96	1.12	1.40
achilles tendon, donor2	10292-104G4	74.40	12.40	4.13	0.00	8.27	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	32.12	0.00	0.25	3.57	2.80	2.04	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	26.24	0.00	0.70	6.50	2.32	0.00	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	31.22	0.00	1.19	11.99	2.49	0.83	0.24	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.31	0.27	1.36	7.62	1.09	1.63	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.21	1.97	3.37	10.68	1.12	1.69	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	48.01	7.40	12.69	11.84	2.54	2.11	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	38.38	3.54	10.07	7.08	4.08	2.72	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.98	0.88	5.73	17.18	2.64	3.08	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	30.63	11.43	13.88	16.74	1.23	2.45	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	26.40	0.39	2.72	17.86	1.16	0.78	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.03	2.02	0.92	5.15	0.74	0.37	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	15.60	23.40	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.94	2.32	3.95	16.27	2.56	2.79	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	36.51	4.92	6.21	7.25	3.11	1.55	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	32.15	2.92	3.21	12.86	0.88	0.58	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.42	1.86	2.32	14.87	0.46	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.15	1.23	2.88	10.28	1.23	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.28	0.31	2.15	3.07	1.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.04	4.27	5.97	10.67	4.69	1.28	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	38.52	7.28	8.19	10.01	1.82	0.61	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.01	6.26	9.39	8.91	2.89	1.20	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.83	1.56	0.67	9.58	1.56	0.22	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.68	0.00	1.33	9.34	4.00	1.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	0.00	1.86	11.15	5.57	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	36.16	1.13	1.51	9.04	1.88	2.64	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.63	1.31	9.16	19.63	0.44	4.36	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	1.87	3.75	20.62	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	66.41	2.83	3.77	3.53	2.59	1.88	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	51.65	4.19	7.76	5.27	6.52	1.55	0.93	0.47
adipose, donor1	10184-103D4	10.56	1.17	5.28	36.36	4.10	6.45	0.00	0.00
adipose, donor2	10185-103D5	12.17	0.81	3.65	13.38	1.62	2.03	0.00	0.41
adipose, donor3	10186-103D6	8.44	1.09	1.63	12.53	1.63	1.91	0.00	0.00
adipose, donor4	10187-103D7	13.00	0.00	1.73	13.00	0.87	1.73	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	33.30	0.32	1.58	10.57	0.95	3.63	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	0.00	14.55	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	32.68	0.00	1.47	17.74	3.20	2.00	0.40	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.80	2.14	5.36	0.71	3.22	1.07	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	35.01	1.16	2.09	2.09	1.62	0.93	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	36.52	4.40	14.20	1.01	3.38	3.38	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	25.34	0.00	7.66	1.18	2.06	2.95	0.29	0.00
amygdala - adult, donor10196	10167-103B5	23.72	8.30	7.11	9.49	0.00	17.79	0.00	0.00
amygdala, adult, donor10252	10151-102I7	44.00	11.96	18.65	18.05	1.22	17.03	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	16.78	4.84	3.23	4.20	2.26	2.26	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	55.90	28.27	12.86	7.77	7.00	1.53	0.89	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.32	3.75	1.99	7.94	1.76	1.10	1.10	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	39.42	0.00	1.00	14.03	0.33	1.00	0.67	0.33
aorta, adult, pool1	10052-101G7	45.11	5.69	4.90	5.10	2.16	3.14	2.16	0.00
appendix, adult	10189-103D9	41.14	6.99	7.37	9.31	5.43	9.70	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	10.66	0.34	6.19	8.94	0.00	6.53	0.34	0.34
artery, adult	10190-103E1	29.89	4.08	6.79	4.08	8.15	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	45.78	24.05	7.10	5.79	2.46	2.03	0.29	0.58
b cell line:RPMI1788	10427-106D4	16.80	1.78	6.39	5.50	0.59	5.95	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.24	4.72	4.16	3.88	2.77	0.83	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	37.71	7.14	5.06	6.35	3.18	1.29	0.30	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	67.45	8.37	2.51	8.03	10.04	1.34	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.08	2.80	1.12	11.74	2.24	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	86.91	16.08	13.91	5.11	6.30	3.91	0.76	0.43
blood, adult, pool1	10053-101G8	37.65	2.21	4.43	6.64	2.21	11.07	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	51.38	10.28	5.14	3.43	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	41.16	4.72	9.45	6.75	3.37	4.05	0.67	0.67
brain, adult, donor1	10084-102B3	21.53	0.00	10.25	14.35	4.10	9.23	1.03	0.00
brain, adult, pool1	10012-101C3	28.28	6.79	15.03	10.58	2.78	18.04	0.22	0.33
brain, fetal, pool1	10085-102B4	2.67	0.00	2.67	5.34	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	41.30	4.63	2.97	0.00	2.31	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.83	11.61	7.24	0.12	3.50	2.75	0.37	0.25
breast, adult, donor1	10080-102A8	42.30	2.53	3.79	6.94	3.16	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.41	3.43	1.27	10.54	1.14	0.25	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	34.32	8.97	6.80	3.71	1.86	5.26	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.63	1.84	5.06	9.44	1.15	2.07	0.69	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.19	7.50	2.91	9.20	5.57	1.94	0.97	0.24
carcinoid cell line:NCI-H1770	10703-109H1	19.28	0.00	2.82	12.22	2.35	0.94	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	48.35	4.27	2.52	8.86	5.80	0.88	0.88	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	20.60	8.56	4.75	7.61	1.58	1.27	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	39.39	3.19	2.93	8.52	2.13	1.06	1.86	0.27
caudate nucleus - adult, donor10196	10177-103C6	32.24	10.36	12.66	12.66	0.00	14.97	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	50.53	15.06	13.55	10.88	0.84	12.38	1.67	0.50
caudate nucleus, adult, donor10258	10379-105H1	13.75	0.76	5.35	12.23	0.00	9.17	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	19.41	11.35	4.39	5.49	3.30	6.23	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	34.96	2.91	49.53	11.65	0.00	43.70	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	41.85	5.76	80.71	11.10	1.92	71.95	0.21	0.43
cerebellum, adult, pool1	10083-102B2	14.14	1.03	12.42	8.97	3.10	11.73	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	9.13	9.13	29.06	18.27	3.32	24.08	0.00	1.66
cerebral meninges, adult	10188-103D8	30.51	3.78	10.34	4.29	2.27	8.82	0.50	0.76
cerebrospinal fluid, donor2	10294-104G6	27.77	5.12	1.46	4.39	7.31	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	35.80	10.78	5.32	12.65	3.31	1.73	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	56.34	11.27	6.30	2.65	4.64	3.15	2.49	0.50
cervix, adult, pool1	10013-101C4	64.99	12.70	26.14	5.46	7.35	8.50	1.89	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	56.01	13.10	3.20	5.02	6.13	0.70	0.28	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	2.61	2.61	2.61	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.11	2.11	1.12	12.80	3.48	0.12	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	20.70	1.11	1.23	7.39	2.09	0.62	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	21.11	0.00	0.47	4.03	2.37	0.24	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	33.91	1.14	4.56	1.71	1.42	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	59.46	4.87	4.67	1.99	6.86	0.89	0.60	0.40
chorionic membrane cells, donor3	12240-129G8	48.90	4.95	4.40	4.95	2.20	0.55	0.55	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	0.00	0.00	1.01	1.01	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	36.11	3.46	7.88	14.22	3.65	2.88	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	33.58	1.27	2.11	14.78	1.90	2.75	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.48	0.00	0.77	13.35	1.28	1.80	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	32.65	0.00	2.18	19.59	0.73	1.45	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.82	0.00	1.43	17.92	1.43	1.43	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	42.40	0.00	1.47	23.56	1.47	2.65	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	50.82	2.61	10.95	13.03	2.35	5.99	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.40	3.89	10.06	7.09	1.14	2.06	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	59.17	7.11	1.39	3.64	3.12	1.21	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	40.82	2.20	1.83	6.22	4.21	0.37	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	28.51	0.38	1.90	12.16	0.76	1.90	0.00	0.00
colon, adult, donor1	10082-102B1	28.56	0.00	4.76	9.52	1.19	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	62.86	4.47	9.52	6.11	11.75	4.58	0.82	0.12
colon, fetal, donor1	10070-101I7	34.61	7.42	9.89	1.85	2.47	6.18	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	178.76	4.58	4.58	36.67	18.33	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	72.24	2.12	6.37	8.50	30.17	2.55	0.85	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	27.62	0.45	2.72	6.19	18.56	1.81	0.45	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	35.68	1.69	2.26	4.65	13.68	1.27	0.56	0.28
corpus callosum, adult, pool1	10042-101F6	41.68	4.42	14.26	29.74	2.43	24.54	0.55	0.33
cruciate ligament, donor2	10295-104G7	71.32	14.59	7.29	5.67	5.67	4.86	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	3.21	4.82	5.62	0.80	1.61	0.80	0.00
diencephalon, adult	10193-103E4	27.12	4.80	10.80	12.96	0.48	21.12	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	20.44	0.46	3.90	5.51	1.15	2.07	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	75.91	12.05	4.87	1.80	5.64	1.03	1.54	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	25.52	1.69	1.69	13.72	2.89	0.48	1.44	0.48
ductus deferens, adult	10196-103E7	41.36	5.98	16.45	3.99	3.49	5.98	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	48.97	1.44	11.52	14.40	1.44	4.32	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	37.52	3.68	10.30	5.15	3.68	2.94	2.94	0.00
dura mater, adult, donor1	10041-101F5	59.13	20.23	9.25	4.96	9.17	3.39	3.06	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	27.31	2.22	2.44	5.33	10.22	1.33	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.92	1.00	1.15	2.44	2.87	0.43	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	53.65	4.32	6.17	17.27	2.47	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	39.35	4.24	1.82	19.07	3.63	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	46.93	4.94	3.09	17.29	4.32	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	51.23	6.57	3.94	18.39	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	62.68	2.01	1.68	5.03	4.36	1.01	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	60.17	1.27	3.08	11.06	4.35	2.36	1.27	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.25	3.06	2.09	0.80	1.61	0.64	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	71.03	17.45	4.78	3.00	7.23	1.56	1.11	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	50.70	12.87	7.48	4.62	4.07	0.66	0.22	0.22
epididymis, adult	10197-103E8	42.28	8.58	11.93	6.49	9.63	7.12	0.84	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.72	0.89	1.42	6.21	1.06	0.89	0.35	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.47	1.18	0.39	2.36	3.54	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	38.14	7.86	3.28	5.37	2.62	0.79	0.13	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	63.58	15.85	6.00	6.50	5.31	1.38	1.28	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	41.79	6.39	2.69	5.27	2.69	0.45	0.45	0.22
esophagus, adult, pool1	10015-101C6	109.15	23.89	10.19	3.08	14.44	5.73	2.97	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.29	10.77	6.51	0.50	12.90	4.76	3.76	1.00
eye - muscle inferior rectus, donor1	10272-104E2	38.63	19.32	0.00	2.41	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	35.77	2.10	2.10	12.63	2.10	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	28.28	0.00	2.98	5.95	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	58.47	6.88	4.59	10.32	3.44	3.44	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	52.47	4.37	7.29	4.37	4.37	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	41.44	13.73	17.80	7.63	2.03	11.69	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	25.64	1.80	1.67	4.87	1.80	0.64	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.68	3.80	3.80	9.50	2.61	0.47	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	21.95	2.91	13.60	18.76	1.78	17.08	0.28	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	28.82	8.11	3.90	6.00	1.50	2.10	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	38.95	12.71	10.42	10.61	2.38	0.64	0.09	0.27
gall bladder, adult	10198-103E9	33.80	4.83	6.52	5.79	5.55	3.38	1.69	0.24
gamma delta positive T cells, donor1	11937-126A2	24.16	1.07	15.57	6.44	5.37	15.57	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	32.12	3.36	16.06	6.35	6.72	14.94	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.74	3.17	3.80	7.60	5.49	0.00	0.84	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	102.12	6.00	2.32	3.87	7.16	0.39	1.93	0.58
gastric cancer cell line:AZ521	10549-107H9	67.06	0.66	0.82	14.43	7.05	3.44	1.80	0.66
gastric cancer cell line:GSS	10560-108A2	17.39	0.00	0.00	10.98	0.92	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	38.38	2.51	3.66	14.39	2.28	0.69	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	46.58	2.07	2.18	13.42	4.02	0.69	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	60.32	22.53	16.24	11.62	5.46	3.64	1.54	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	68.09	27.69	8.23	5.49	5.99	2.74	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.76	1.27	4.96	5.59	2.53	1.58	1.16	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	26.12	1.12	4.49	4.92	2.11	1.26	0.70	0.14
glioblastoma cell line:T98G	10485-107A8	154.74	41.61	12.80	8.72	7.84	3.09	3.09	0.77
glioma cell line:GI-1	10413-106B8	24.31	9.96	4.39	9.96	2.64	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	25.51	5.83	15.31	21.87	0.73	18.22	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	81.53	13.67	25.63	26.36	1.46	41.25	0.98	0.49
globus pallidus, adult, donor10258	10367-105F7	19.17	0.00	16.43	15.06	1.37	26.01	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.39	1.60	2.13	8.53	3.20	1.60	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	168.85	4.89	4.89	19.58	17.13	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	20.91	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.04	4.16	4.16	8.64	2.88	1.60	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	17.91	0.00	0.92	2.75	0.46	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	10.06	0.46	0.46	1.83	0.91	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	0.00	0.00	1.93	0.64	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	0.00	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.92	0.00	0.69	2.74	0.69	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	9.93	0.00	3.31	13.24	1.10	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	26.44	3.45	4.31	6.03	3.16	3.16	2.30	1.15
heart - mitral valve, adult	10205-103F7	83.11	15.25	14.65	8.37	7.47	5.68	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	47.33	6.01	10.98	4.97	2.61	7.32	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	134.06	9.16	1.67	7.49	8.33	0.83	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	22.65	1.84	1.63	5.31	3.06	0.82	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	16.18	1.70	0.43	5.11	1.70	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	54.73	2.30	2.53	1.61	3.91	1.15	1.38	0.23
heart, fetal, pool1	10046-101G1	46.10	4.00	18.17	9.55	1.64	8.83	0.31	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	44.12	7.10	3.09	7.10	2.16	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	3.57	4.76	4.76	4.76	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	155.91	20.55	4.42	9.39	12.93	3.76	0.33	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	154.99	25.37	6.68	9.10	13.47	4.25	0.36	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	171.99	27.39	8.39	13.04	13.84	4.55	0.20	1.72
hepatoma cell line:Li-7	10484-107A7	51.72	2.89	1.89	7.56	5.45	0.56	1.11	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.99	0.10	0.60	6.33	0.90	0.40	0.40	0.10
hippocampus - adult, donor10196	10169-103B7	19.87	2.84	10.41	13.25	0.95	14.19	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	51.02	8.98	30.00	16.94	1.63	30.21	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	11.95	1.49	3.98	6.97	1.49	5.48	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.22	2.47	1.41	7.75	2.11	0.70	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.82	2.44	1.22	5.49	0.61	0.61	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.57	0.00	0.59	2.95	0.98	0.79	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	11.43	0.51	0.76	4.57	1.78	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	0.56	0.56	16.35	0.56	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	7.75	0.52	0.52	19.11	2.07	2.07	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.69	0.00	1.90	18.60	2.28	2.28	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.80	1.17	6.42	14.31	1.75	2.04	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.26	1.08	3.23	21.33	1.51	2.15	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	1.67	2.09	17.93	1.67	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.95	3.08	5.92	4.50	1.42	4.74	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.36	3.21	4.50	6.59	1.29	3.70	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	13.47	1.35	8.08	7.41	2.69	2.02	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.87	0.94	0.47	2.82	2.66	0.31	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	9.83	0.98	1.47	2.46	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	11.35	1.75	5.24	1.75	2.62	1.75	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.74	0.38	0.95	20.81	4.01	1.53	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	5.67	0.44	0.00	15.70	2.62	2.18	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5.50	1.50	1.50	15.99	0.50	2.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.17	2.07	5.65	11.30	2.07	8.10	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.46	1.36	7.28	13.19	1.36	5.46	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.01	2.51	4.70	13.78	0.94	4.07	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.19	1.14	4.74	6.86	2.12	3.76	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.58	2.03	4.64	6.97	0.58	3.77	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.07	1.79	2.99	5.98	3.59	1.20	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.23	0.37	0.37	4.25	1.29	0.37	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.26	0.00	0.29	4.56	1.43	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	0.82	0.41	4.08	0.82	0.82	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.86	0.00	0.70	11.62	1.76	1.41	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	0.00	0.95	11.40	4.12	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.36	0.00	0.30	11.80	3.03	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.76	1.55	5.17	10.86	2.07	4.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	0.00	2.66	9.96	0.66	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.90	0.77	3.59	10.26	2.05	1.80	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.67	1.79	6.90	6.65	1.53	2.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.09	0.76	2.27	9.84	0.00	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	10.75	2.02	3.36	7.39	1.68	4.37	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.08	0.00	0.48	1.93	2.42	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	15.15	0.45	0.45	0.89	2.23	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.71	0.49	0.49	3.41	3.90	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	8.56	0.00	2.14	15.89	2.14	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	6.51	6.51	42.29	6.51	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.95	0.66	1.99	17.21	0.99	1.65	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.76	1.09	3.83	10.95	2.74	2.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.43	2.90	3.98	13.03	0.36	2.90	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2.85	1.07	2.85	13.52	1.78	3.91	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	0.00	2.39	2.39	2.39	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.49	2.30	8.13	4.60	3.39	5.69	0.14	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.00	0.81	3.77	5.39	2.16	1.89	0.27	0.00
immature langerhans cells, donor1	11904-125F5	129.31	35.84	61.26	0.00	21.31	30.99	3.15	0.97
immature langerhans cells, donor2	11905-125F6	125.95	15.84	19.01	0.79	8.71	12.67	0.79	0.79
insula, adult, pool1	10039-101F3	15.24	2.84	6.81	17.98	1.70	10.98	0.28	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	57.55	6.18	0.98	3.58	5.53	0.33	1.63	0.00
kidney, adult, pool1	10017-101C8	60.38	5.61	10.31	5.91	7.31	6.81	1.00	0.40
kidney, fetal, pool1	10045-101F9	47.68	2.55	7.99	6.93	2.62	6.08	0.71	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.13	5.40	7.95	4.54	6.39	3.12	8.24	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.63	4.56	2.07	6.77	1.94	0.14	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	32.30	5.32	3.12	4.04	1.28	1.28	0.18	0.73
left atrium, adult, donor1	10079-102A7	23.97	4.36	9.26	5.99	2.18	3.81	0.00	0.00
left ventricle, adult, donor1	10078-102A6	27.31	2.53	3.54	4.55	2.02	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	46.24	4.65	2.19	10.12	1.37	0.00	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	11.14	5.75	4.67	0.36	1.08	0.72	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	13.59	3.26	0.54	0.54	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	19.18	6.31	6.56	2.19	1.70	0.73	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	0.00	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	3.14	1.05	4.18	1.05	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.52	2.01	3.42	4.37	3.07	1.65	0.59	0.24
liposarcoma cell line:KMLS-1	10782-110G8	32.65	8.44	7.34	5.62	1.87	1.56	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	50.44	9.87	2.80	5.36	5.85	1.71	0.00	0.12
liver, adult, pool1	10018-101C9	40.03	4.21	1.94	2.43	3.24	0.65	0.00	0.49
liver, fetal, pool1	10086-102B5	11.29	0.00	0.94	2.82	4.70	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	37.48	3.65	12.69	17.35	1.75	16.92	0.73	0.29
locus coeruleus, adult, donor10252	10165-103B3	54.63	13.66	23.25	20.12	0.55	30.64	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	9.03	1.97	10.44	13.26	1.13	17.21	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	20.61	8.83	11.36	7.99	3.79	8.83	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	40.83	9.83	4.57	5.54	2.21	1.52	0.28	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	35.85	9.65	6.20	12.41	1.38	2.76	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	57.74	7.38	7.91	8.96	6.33	3.56	4.22	0.26
lung, adult, pool1	10019-101D1	62.49	10.63	11.34	5.20	6.14	4.02	3.54	0.12
lung, fetal, donor1	10068-101I5	96.47	17.98	57.65	9.99	4.85	13.13	7.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	35.28	10.54	16.50	10.54	5.50	5.96	0.92	0.92
lymph node, adult, donor1	10077-102A5	32.19	2.37	1.42	7.10	2.37	3.79	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	18.63	0.22	0.88	5.26	0.66	1.75	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	24.90	0.45	5.89	6.64	3.92	7.40	0.00	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.85	11.04	5.95	4.25	11.04	0.85	0.85	0.85
mature adipocyte, donor1	12231-129F8	47.95	3.55	1.33	7.55	3.11	0.00	2.66	0.00
mature adipocyte, donor2	12232-129F9	59.98	5.81	3.53	7.06	4.15	1.25	2.08	0.21
mature adipocyte, donor3	12233-129G1	66.14	7.82	3.79	7.35	4.98	0.47	0.95	0.00
mature adipocyte, donor4	12234-129G2	55.28	7.11	5.79	5.26	3.95	0.79	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	47.18	4.05	5.48	16.20	5.96	1.91	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	16.92	7.90	11.28	15.79	0.00	10.15	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	52.23	11.22	18.02	15.63	0.92	20.41	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	1.59	4.77	10.17	0.95	9.85	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	17.06	15.35	8.53	10.24	3.84	8.10	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	15.02	5.06	14.51	14.51	0.51	17.21	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	53.48	9.55	19.74	19.52	0.64	25.47	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	0.00	7.71	5.78	3.85	7.71	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	100.48	57.41	0.00	0.00	114.83	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.33	2.15	1.44	6.46	2.15	2.87	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	24.66	7.14	13.63	11.68	1.30	16.22	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	68.27	12.23	29.26	16.41	1.08	30.96	1.08	0.31
medulla oblongata, adult, pool1	10038-101F2	30.04	4.41	10.12	18.53	1.96	13.63	1.14	0.24
medulla oblongata, newborn, donor10223	10361-105F1	33.33	8.68	12.15	8.68	1.39	6.25	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	76.17	23.47	10.85	20.37	3.54	3.54	0.66	0.66
medulloblastoma cell line:ONS-76	10759-110E3	20.66	1.10	1.35	5.38	0.98	0.12	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	52.61	12.36	7.19	6.76	10.21	2.30	0.72	0.29
melanoma cell line:G-361	10465-106H6	40.72	4.34	2.99	6.52	7.60	0.81	1.90	0.27
meningioma cell line:HKBMM	10691-109F7	37.99	7.42	5.25	4.52	1.63	0.54	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	0.00	1.76	8.81	0.88	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	23.59	2.33	5.70	6.22	3.11	2.07	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.76	3.38	3.53	1.53	2.61	0.46	0.77	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.17	5.45	4.54	2.00	3.27	0.73	0.91	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	25.67	2.48	2.07	1.66	0.83	0.00	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.85	2.67	2.53	1.40	1.26	0.28	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.78	3.08	2.89	2.50	1.73	0.77	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	22.90	6.94	2.78	2.08	3.47	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	48.23	6.87	3.78	1.54	6.69	1.72	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	36.46	3.11	2.99	1.73	3.22	1.15	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.31	8.62	4.64	1.19	3.32	0.53	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	34.30	4.73	3.51	1.89	1.49	0.00	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.44	2.13	2.42	1.14	1.71	0.71	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.03	1.98	1.32	5.27	2.63	0.00	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	26.57	3.74	3.04	1.94	1.25	0.83	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.23	9.08	4.89	1.05	1.05	0.35	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.23	1.63	3.47	1.22	1.02	2.04	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	2.16	1.44	2.16	2.88	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.10	2.59	4.86	3.10	0.52	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	0.91	0.68	2.05	1.60	1.37	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.01	3.78	10.07	2.10	0.84	0.84	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	3.44	1.64	1.34	1.79	0.60	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.47	2.98	5.16	1.84	2.10	0.96	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.88	2.21	1.84	2.95	0.74	0.74	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	2.00	1.14	2.86	2.29	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	5.89	10.53	2.95	1.26	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	30.60	6.39	1.37	2.28	1.37	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.37	8.95	4.60	2.05	2.05	0.00	1.28	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	8.11	4.19	1.57	1.57	0.26	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	33.89	4.62	2.16	3.39	1.54	0.62	1.85	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.54	9.88	4.47	2.82	2.35	0.24	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.81	9.48	1.69	0.68	1.69	0.00	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.15	7.07	2.36	0.79	1.96	0.79	1.96	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	8.34	6.02	0.93	3.71	0.46	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	40.38	12.11	4.33	5.48	3.17	1.73	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.02	8.92	2.23	2.45	2.23	0.45	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.65	10.09	3.12	2.40	0.48	0.72	1.44	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	9.53	3.67	2.93	2.20	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.20	7.72	3.02	1.34	1.01	0.34	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	8.19	1.64	1.23	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.63	8.16	2.58	2.58	2.58	0.43	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	5.47	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	5.52	1.95	2.27	1.62	0.32	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	5.82	1.45	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	31.45	2.67	0.00	3.73	3.73	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	4.09	0.82	2.45	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	4.66	0.39	1.17	1.94	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	3.97	0.99	0.00	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.75	4.74	1.19	1.19	1.78	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	17.06	8.53	1.22	3.66	3.66	0.00	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	3.17	1.90	0.63	3.17	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.45	5.86	4.14	0.34	3.45	0.69	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	2.15	0.00	2.15	4.30	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	20.78	12.22	1.63	1.22	1.22	0.41	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	9.53	1.59	1.59	1.59	0.00	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.12	12.97	1.18	1.18	2.36	0.59	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.61	11.22	2.18	3.43	0.94	0.31	2.18	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	12.03	0.00	1.34	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	8.28	0.00	7.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	12.84	5.14	5.14	2.57	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	29.60	14.46	3.44	3.44	1.38	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.38	7.92	2.97	3.96	0.00	0.49	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	4.49	2.24	4.49	1.12	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.81	8.27	3.18	3.82	0.64	0.00	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.70	2.01	1.21	4.03	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	4.36	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	0.00	0.00	3.80	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	4.86	2.43	4.25	3.64	0.00	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	4.12	1.65	3.29	1.65	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.20	9.72	4.37	4.37	3.37	0.40	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.39	7.14	1.30	3.24	1.95	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	25.47	5.09	2.04	2.04	3.06	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.88	1.55	3.87	7.74	1.55	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	46.30	7.32	3.78	5.67	4.25	1.89	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	46.80	22.47	6.02	1.39	4.17	2.55	3.71	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	0.00	17.09	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.08	5.75	3.70	3.70	2.06	1.03	1.03	0.10
mesothelioma cell line:Mero-25	10850-111F4	18.16	7.72	2.95	2.95	2.72	1.59	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	37.65	6.60	3.67	6.36	3.91	0.24	1.47	0.24
mesothelioma cell line:Mero-48a	10852-111F6	20.37	1.99	6.20	5.76	1.33	3.10	0.89	0.00
mesothelioma cell line:Mero-82	10853-111F7	47.57	7.36	3.68	6.31	5.26	0.79	3.94	0.53
mesothelioma cell line:Mero-83	10854-111F8	16.34	1.70	3.92	2.89	0.34	1.70	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	23.76	3.29	1.01	2.53	0.76	0.76	2.53	0.51
mesothelioma cell line:Mero-95	10856-111G1	27.74	12.63	7.87	2.69	1.86	1.04	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	25.18	1.66	3.31	3.31	2.15	0.50	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	28.96	3.26	2.90	3.62	2.35	0.36	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	30.24	4.78	7.86	4.10	1.20	1.02	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	47.33	9.42	16.03	3.05	1.78	3.82	0.25	0.25
mesothelioma cell line:No36	10857-111G2	17.61	1.63	1.63	6.52	0.33	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	29.80	4.34	2.17	5.96	4.34	0.27	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	77.34	7.29	33.01	1.34	7.48	24.95	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	57.64	3.66	13.07	3.54	8.67	10.38	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	65.15	5.20	24.23	4.13	8.79	22.44	0.72	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.44	2.61	0.65	16.32	0.98	0.33	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	76.51	16.11	6.57	7.63	3.81	0.85	0.85	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.06	2.07	0.69	9.68	3.23	0.23	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.51	0.38	1.33	7.04	3.04	1.14	1.14	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	38.25	11.09	5.91	17.00	0.92	1.85	0.18	0.00
myeloma cell line:PCM6	10474-106I6	33.21	0.00	1.38	12.85	3.56	0.40	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.96	2.54	3.55	6.59	0.51	0.00	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	42.37	1.96	0.59	6.08	3.92	0.00	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	69.08	3.79	2.12	3.34	3.79	1.78	0.56	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	57.51	7.06	1.84	3.46	3.53	1.18	0.29	0.15
nasal epithelial cells, donor2	12227-129F4	37.54	7.73	3.86	1.66	5.52	2.21	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	61.89	17.94	19.10	26.00	3.45	3.45	0.23	1.38
neuroblastoma cell line:NB-1	10539-107G8	48.64	1.31	9.17	5.43	2.62	5.99	0.37	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	20.46	0.84	0.84	6.54	1.69	0.84	1.05	0.21
neuroblastoma cell line:NH-12	10555-107I6	30.75	0.75	4.47	15.47	2.61	2.98	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.84	1.90	3.80	5.93	0.71	1.90	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.70	2.06	1.58	2.38	3.17	0.63	3.80	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	16.91	2.01	2.01	7.65	0.60	0.40	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.79	0.64	0.64	2.54	0.64	0.64	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	40.99	3.73	3.19	4.26	2.93	0.53	0.53	0.27
neutrophil PMN, donor1	12133-128D9	520.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	46.17	0.17	3.38	33.99	3.38	5.58	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	49.63	7.20	13.61	7.20	1.60	3.20	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	58.03	13.47	11.86	3.21	4.49	2.56	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	114.04	25.49	7.09	3.42	10.25	5.78	2.36	0.53
nucleus accumbens, adult, pool1	10037-101F1	21.00	3.66	9.66	17.06	1.69	13.31	0.66	0.37
occipital cortex - adult, donor10196	10172-103C1	14.42	2.06	6.18	16.48	2.06	18.54	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	66.82	10.73	21.74	22.27	1.88	29.52	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	10.19	2.91	1.82	4.73	0.36	3.28	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	16.01	2.10	8.92	15.48	2.10	12.33	0.52	0.79
occipital lobe, fetal, donor1	10073-102A1	3.43	0.00	2.15	18.88	0.86	2.57	0.00	0.43
occipital pole, adult, pool1	10036-101E9	13.88	1.26	1.81	9.86	0.95	4.65	0.32	0.39
olfactory region, adult	10195-103E6	21.21	3.44	9.36	14.14	1.53	13.18	0.19	0.19
optic nerve, donor1	10277-104E7	30.02	8.00	12.01	48.03	16.01	16.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	58.55	19.48	7.06	7.29	8.66	2.85	0.80	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	131.34	29.40	7.01	10.72	7.97	3.98	1.37	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	49.27	10.67	3.22	1.35	5.42	0.85	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	56.14	3.12	1.39	3.93	3.70	0.35	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	27.93	1.18	2.35	5.00	2.65	0.29	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	53.26	2.80	0.93	10.28	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	18.87	0.85	1.48	7.21	1.06	1.06	0.21	0.00
ovary, adult, pool1	10020-101D2	89.88	24.46	25.42	3.84	6.03	11.44	2.18	1.48
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.95	1.65	1.65	8.07	1.28	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	25.40	0.00	5.64	6.58	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.58	0.28	0.00	7.27	1.12	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	35.26	10.39	3.92	1.87	3.92	1.19	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.52	15.56	7.12	10.10	4.97	2.15	0.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	21.60	1.74	6.86	14.46	1.83	10.89	1.10	0.27
parietal cortex, adult, donor10258	10373-105G4	16.88	1.47	4.40	7.34	0.73	6.61	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	0.00	11.29	13.17	0.00	17.87	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	45.32	10.55	16.53	15.39	0.86	21.66	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	22.21	1.67	7.05	16.13	1.32	11.54	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	3.88	0.00	4.85	23.28	1.94	4.85	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	14.95	4.11	2.62	7.48	2.24	4.86	0.75	0.37
parotid gland, adult	10199-103F1	35.15	0.00	1.85	1.85	4.32	1.23	0.62	0.00
penis, adult	10200-103F2	33.30	5.37	9.13	3.22	5.91	5.37	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.66	0.93	2.42	0.56	2.42	1.67	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	94.12	21.85	6.70	4.08	8.01	5.54	2.04	0.58
pineal gland - adult, donor10196	10179-103C8	25.80	16.13	29.03	23.87	0.65	17.42	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	49.75	21.32	84.69	46.19	1.78	50.34	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	11.91	1.25	15.68	21.32	5.02	13.80	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	57.67	28.33	52.61	14.17	6.07	13.15	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	107.88	44.30	106.32	31.79	8.34	51.08	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	15.32	9.36	34.90	19.58	4.26	15.32	0.85	0.00
placenta, adult, pool1	10021-101D3	71.38	3.44	3.66	3.76	4.95	2.80	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	20.00	0.26	2.91	5.96	1.72	2.65	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	76.26	29.88	13.54	9.34	3.89	2.33	0.47	0.16
pons, adult, pool1	10033-101E6	22.98	3.27	13.00	16.27	3.10	21.95	0.69	0.26
postcentral gyrus, adult, pool1	10032-101E5	15.60	2.18	4.10	11.42	0.78	8.19	0.26	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	221.69	0.00	0.00	12.55	8.37	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	16.52	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.76	11.07	7.87	6.55	1.17	1.46	1.60	0.15
prostate cancer cell line:PC-3	10439-106E7	28.68	1.63	2.36	2.90	1.63	1.09	0.36	0.36
prostate, adult, pool1	10022-101D4	69.47	17.87	23.94	5.44	5.89	6.98	1.09	0.09
putamen, adult, donor10196	10176-103C5	32.10	11.80	14.16	11.80	1.18	17.23	0.94	0.47
putamen, adult, donor10252	10152-102I8	33.33	7.84	11.76	11.76	0.00	7.84	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	2.19	1.09	4.37	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	15.22	3.87	9.66	6.04	1.21	8.94	0.00	0.24
putamen, newborn, donor10223	10365-105F5	13.49	19.49	11.99	5.25	2.25	6.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	41.02	1.75	1.45	0.29	3.20	0.87	0.58	0.29
rectum, fetal, donor1	10067-101I4	18.08	1.39	13.91	16.69	2.78	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.86	5.51	10.18	9.33	2.54	2.33	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.55	32.72	7.04	3.31	0.41	2.07	0.00	0.83
retina, adult, pool1	10030-101E3	40.55	11.13	10.93	13.92	2.98	8.65	1.49	0.40
retinoblastoma cell line:Y79	10475-106I7	22.86	0.26	1.30	20.78	0.52	1.82	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.54	1.97	2.34	3.93	1.60	0.86	0.12	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	102.36	0.00	3.66	8.72	5.34	2.25	1.12	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	107.62	7.58	4.55	3.79	9.09	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	59.73	24.93	4.86	3.24	7.28	1.13	1.13	0.49
salivary acinar cells, donor2	11772-123I8	79.03	30.70	5.78	3.03	9.78	2.89	4.41	0.28
salivary acinar cells, donor3	11773-123I9	84.08	13.24	3.97	1.99	5.96	2.65	2.65	0.00
salivary gland, adult, pool1	10093-102C3	33.17	3.43	8.01	2.29	2.29	2.29	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.09	2.19	1.85	2.36	2.11	0.67	0.17	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.87	2.35	0.94	2.70	1.76	0.94	0.12	0.12
seminal vesicle, adult	10201-103F3	45.50	2.65	10.58	6.35	4.76	3.17	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	94.98	8.02	5.83	10.20	9.23	1.94	1.70	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.25	2.01	1.26	1.01	2.26	0.75	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	26.09	1.00	3.01	2.01	2.01	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	73.07	5.91	2.15	3.36	3.36	0.67	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	42.77	7.52	3.32	1.88	4.97	0.99	0.77	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	106.06	16.13	7.35	1.03	8.52	3.35	1.16	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	0.71	0.00	9.22	4.26	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	64.29	3.24	5.16	3.00	6.12	1.08	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	14.07	1.01	0.00	2.01	1.01	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	39.14	8.84	12.62	10.10	5.05	3.79	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.36	9.01	3.34	2.33	3.34	0.33	1.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	37.82	12.29	23.01	12.92	5.36	2.21	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	18.31	0.39	0.39	3.66	0.58	0.77	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	52.74	19.94	16.15	6.10	7.42	4.62	1.65	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.59	0.48	1.13	2.90	0.64	0.97	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.29	15.04	10.90	0.00	6.32	3.49	5.01	0.00
small intestine, adult, pool1	10024-101D6	76.68	5.85	9.67	3.46	12.90	5.26	0.72	0.12
small intestine, fetal, donor1	10064-101I1	26.04	1.72	4.42	3.19	1.72	3.69	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	47.19	5.13	9.23	13.85	12.31	2.05	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	77.02	12.66	8.01	7.50	6.72	4.14	1.81	1.03
somatostatinoma cell line:QGP-1	10781-110G7	81.75	4.82	3.75	5.63	5.90	1.88	1.34	0.00
spinal cord - adult, donor10196	10181-103D1	33.72	10.09	28.22	16.06	2.29	28.68	0.92	0.69
spinal cord, adult, donor10252	10159-103A6	74.91	17.74	42.58	16.17	1.58	42.98	1.58	0.79
spinal cord, adult, donor10258	10369-105F9	13.14	2.77	15.22	10.38	2.08	23.52	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	25.00	1.22	4.27	12.81	3.66	9.15	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	22.50	25.26	23.88	17.91	5.97	15.15	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.15	2.69	2.09	3.73	3.88	0.15	0.15	0.15
spleen, adult, pool1	10025-101D7	47.47	4.96	14.76	4.41	4.19	8.81	1.21	0.22
spleen, fetal, pool1	10044-101F8	36.15	2.38	7.15	6.91	4.93	3.65	0.95	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.77	0.41	4.04	3.31	2.79	3.21	0.31	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	130.63	36.08	7.78	5.70	5.70	4.37	0.57	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.99	4.89	3.49	4.89	2.10	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	1.17	0.78	5.86	1.17	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.29	14.18	6.08	4.16	3.38	1.58	0.00	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	74.55	10.17	2.54	4.24	5.08	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	47.81	1.69	1.69	5.08	4.23	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	54.47	1.07	7.48	4.27	8.54	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	35.32	1.14	4.56	5.13	3.42	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	217.10	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	69.17	11.84	32.61	23.89	1.45	62.31	0.83	0.21
substantia nigra, adult, donor10258	10371-105G2	12.93	4.66	8.28	9.83	0.52	5.17	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.73	5.65	9.89	9.19	1.41	9.19	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.30	0.46	0.69	5.50	1.60	3.44	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	14.16	1.44	4.49	9.32	1.78	5.51	0.34	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.12	0.71	2.14	4.99	0.71	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.11	0.88	4.83	7.03	1.32	2.64	0.44	0.44
tenocyte, donor1	11763-123H8	34.21	4.19	3.49	1.75	0.70	0.00	0.35	0.00
tenocyte, donor2	11765-123I1	47.69	9.16	4.20	2.67	2.67	0.76	1.53	0.38
tenocyte, donor3	11768-123I4	37.07	4.82	2.59	2.59	0.74	0.74	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	35.18	1.70	3.23	6.12	2.38	0.85	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.18	0.31	1.08	5.24	0.92	1.85	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	22.01	0.15	0.46	14.10	2.79	0.46	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	23.99	0.76	0.63	0.51	2.41	0.51	0.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.82	0.38	1.89	1.89	2.65	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.12	0.22	6.11	3.05	3.27	9.05	0.55	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.35	0.00	0.00	6.51	2.28	0.65	0.33	0.00
testis, adult, pool1	10026-101D8	63.89	7.73	13.53	5.91	5.91	7.30	1.29	7.95
testis, adult, pool2	10096-102C6	29.77	0.90	1.35	13.98	3.61	4.06	0.00	8.57
thalamus - adult, donor10196	10168-103B6	29.81	8.83	14.35	14.35	0.00	27.60	0.00	0.00
thalamus, adult, donor10252	10154-103A1	66.42	10.78	28.13	23.75	0.78	52.20	0.63	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	0.00	7.70	4.62	0.00	9.24	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.39	1.15	7.25	12.52	1.15	9.72	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	6.90	2.88	4.60	8.05	1.73	2.30	0.58	0.00
throat, adult	10209-103G2	61.17	13.48	7.99	6.74	10.49	8.24	1.75	0.00
throat, fetal, donor1	10061-101H7	42.05	9.45	15.24	7.01	3.35	7.31	2.74	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	12.92	0.00	0.20	0.20	1.19	0.40	0.20	0.20
thymus, adult, pool1	10027-101D9	43.05	1.29	8.95	4.08	4.18	12.53	0.50	0.30
thymus, fetal, pool1	10043-101F7	44.47	5.40	12.68	9.04	4.57	10.70	0.52	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.66	1.73	2.39	14.76	4.12	0.27	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	26.40	2.79	5.31	5.73	1.12	0.98	3.35	0.14
thyroid, adult, pool1	10028-101E1	90.89	10.17	29.30	5.60	7.65	14.37	21.84	0.37
thyroid, fetal, donor1	10060-101H6	61.96	3.16	11.60	10.55	3.69	7.91	6.86	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	12.32	3.08	3.08	12.32	3.08	3.08	0.00
tongue, adult	10203-103F5	60.00	13.49	5.35	3.49	9.30	3.26	1.86	0.47
tongue, fetal, donor1	10059-101H5	36.26	5.12	10.25	1.97	1.58	5.52	0.00	0.00
tonsil, adult, pool1	10047-101G2	44.88	5.81	4.61	8.62	4.61	6.61	1.90	0.20
trachea, adult, pool1	10029-101E2	95.62	12.35	7.77	2.78	7.93	3.11	2.37	0.41
trachea, fetal, donor1	10058-101H4	42.32	9.62	12.31	5.00	4.23	3.08	2.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.14	4.96	1.42	1.06	2.13	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	51.87	25.94	8.41	7.80	6.48	2.03	0.51	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	62.36	12.85	4.07	8.46	7.05	0.94	1.57	0.94
tridermal teratoma cell line:HGRT	10694-109G1	70.39	3.81	5.71	0.00	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	51.30	5.93	4.66	6.69	3.98	0.85	1.10	0.34
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	4.17	2.09	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	48.46	2.73	13.65	10.92	3.75	7.85	1.54	0.00
uterus, fetal, donor1	10055-101H1	38.91	4.61	18.43	7.17	2.05	8.19	0.51	0.00
vagina, adult	10204-103F6	105.98	9.69	7.75	1.94	4.52	1.94	1.29	1.94
vein, adult	10191-103E2	37.92	3.29	5.92	6.14	1.97	5.04	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	19.76	0.00	1.34	2.67	0.27	2.94	0.00	0.00